{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:00:14Z","timestamp":1781157614909,"version":"3.54.1"},"reference-count":267,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05110-8","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:28:56Z","timestamp":1781155736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of antimicrobial peptide-based biomaterials in respiratory tract infections control"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9257-4479","authenticated-orcid":false,"given":"Hamed","family":"Tahmasebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1517-4225","authenticated-orcid":false,"given":"Meisam","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-8193","authenticated-orcid":false,"given":"Mohammad Reza","family":"Arabestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"5110_CR1","doi-asserted-by":"publisher","unstructured":"Fenker DE, McDaniel CT, Panmanee W, Panos RJ, Sorscher EJ, Sabusap C, et al. A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Int J Respir Pulm Med. 2018;5(2). https:\/\/doi.org\/10.23937\/2378-3516\/1410098.","DOI":"10.23937\/2378-3516\/1410098"},{"issue":"3","key":"5110_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4046\/trd.2018.0030","volume":"81","author":"MI Restrepo","year":"2018","unstructured":"Restrepo MI, Sibila O, Anzueto A. Pneumonia in patients with chronic obstructive pulmonary disease. Tuberc Respir Dis. 2018;81(3):187\u201397. https:\/\/doi.org\/10.4046\/trd.2018.0030.","journal-title":"Tuberc Respir Dis"},{"issue":"6","key":"5110_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.rmed.2013.02.009","volume":"107","author":"K Suresh Babu","year":"2013","unstructured":"Suresh Babu K, Kastelik J, Morjaria JB. Role of long term antibiotics in chronic respiratory diseases. Respir Med. 2013;107(6):800\u201315. https:\/\/doi.org\/10.1016\/j.rmed.2013.02.009.","journal-title":"Respir Med"},{"issue":"1","key":"5110_CR4","doi-asserted-by":"publisher","first-page":"230186","DOI":"10.1183\/20734735.0186-2023","volume":"20","author":"S Pochepnia","year":"2024","unstructured":"Pochepnia S, Grabczak EM, Johnson E, Eyuboglu FO, Akkerman O, Prosch H. Imaging in pulmonary infections of immunocompetent adult patients. Breathe. 2024;20(1):230186. https:\/\/doi.org\/10.1183\/20734735.0186-2023.","journal-title":"Breathe"},{"key":"5110_CR5","doi-asserted-by":"publisher","first-page":"643326","DOI":"10.3389\/fcimb.2021.643326","volume":"11","author":"V Sender","year":"2021","unstructured":"Sender V, Hentrich K, Henriques-Normark B. Virus-induced changes of the respiratory tract environment promote secondary infections with Streptococcus pneumoniae. Front Cell Infect Microbiol. 2021;11:643326. https:\/\/doi.org\/10.3389\/fcimb.2021.643326.","journal-title":"Front Cell Infect Microbiol"},{"key":"5110_CR6","doi-asserted-by":"publisher","first-page":"104941","DOI":"10.1016\/j.micpath.2021.104941","volume":"156","author":"MN Hoque","year":"2021","unstructured":"Hoque MN, Akter S, Mishu ID, Islam MR, Rahman MS, Akhter M, et al. Microbial co-infections in COVID-19: associated microbiota and underlying mechanisms of pathogenesis. Microb Pathog. 2021;156:104941. https:\/\/doi.org\/10.1016\/j.micpath.2021.104941.","journal-title":"Microb Pathog"},{"issue":"1","key":"5110_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17476348.2019.1555040","volume":"13","author":"C Feldman","year":"2019","unstructured":"Feldman C, Shaddock E. Epidemiology of lower respiratory tract infections in adults. Expert Rev Respir Med. 2019;13(1):63\u201377. https:\/\/doi.org\/10.1080\/17476348.2019.1555040.","journal-title":"Expert Rev Respir Med"},{"issue":"2","key":"5110_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s11033-019-05233-4","volume":"47","author":"H Tahmasebi","year":"2020","unstructured":"Tahmasebi H, Dehbashi S, Jahantigh M, Arabestani MR. Relationship between biofilm gene expression with antimicrobial resistance pattern and clinical specimen type based on sequence types (STs) of methicillin-resistant S. aureus. Mol Biol Rep. 2020;47(2):1309\u201320. https:\/\/doi.org\/10.1007\/s11033-019-05233-4.","journal-title":"Mol Biol Rep"},{"key":"5110_CR9","doi-asserted-by":"publisher","unstructured":"Dehbashi S, Tahmasebi H, Zeyni B, Arabestani MR. Regulation of virulence and \u03b2-lactamase gene expression in Staphylococcus aureus isolates: cooperation of two-component systems in bloodstream superbugs. BMC Microbiology. 2021;21(1). https:\/\/doi.org\/10.1186\/s12866-021-02257-4.","DOI":"10.1186\/s12866-021-02257-4"},{"issue":"1","key":"5110_CR10","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1038\/s41598-022-11984-1","volume":"12","author":"H Tahmasebi","year":"2022","unstructured":"Tahmasebi H, Dehbashi S, Nasaj M, Arabestani MR. Molecular epidemiology and collaboration of siderophore-based iron acquisition with surface adhesion in hypervirulent Pseudomonas aeruginosa isolates from wound infections. Sci Rep. 2022;12(1):7791. https:\/\/doi.org\/10.1038\/s41598-022-11984-1.","journal-title":"Sci Rep"},{"key":"5110_CR11","doi-asserted-by":"publisher","unstructured":"Porbaran M, Tahmasebi H, Arabestani M. A Comprehensive Study of the Relationship between the Production of \u03b2 -Lactamase Enzymes and Iron\/Siderophore Uptake Regulatory Genes in Clinical Isolates of Acinetobacter baumannii. Int J Microbiol. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/5565537.","DOI":"10.1155\/2021\/5565537"},{"issue":"10459","key":"5110_CR12","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/s0140-6736(24)01885-3","volume":"404","author":"S Kariuki","year":"2024","unstructured":"Kariuki S. Global burden of antimicrobial resistance and forecasts to 2050. Lancet. 2024;404(10459):1172\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(24)01885-3.","journal-title":"Lancet"},{"key":"5110_CR13","doi-asserted-by":"publisher","unstructured":"Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals (Basel). 2023;16(11). https:\/\/doi.org\/10.3390\/ph16111615.","DOI":"10.3390\/ph16111615"},{"issue":"3","key":"5110_CR14","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s12602-025-10478-6","volume":"17","author":"YZ Wu","year":"2025","unstructured":"Wu YZ, Wang J, Hu YH, Sun QS, Geng R, Ding LN. Antimicrobial peptides: classification, mechanism, and application in plant disease resistance. Probiotics Antimicrob Proteins. 2025;17(3):1432\u201346. https:\/\/doi.org\/10.1007\/s12602-025-10478-6.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"5110_CR15","doi-asserted-by":"publisher","first-page":"1548603","DOI":"10.3389\/fmed.2025.1548603","volume":"12","author":"YF Varela-Quitian","year":"2025","unstructured":"Varela-Quitian YF, Mendez-Rivera FE, Bernal-Estevez DA. Cationic antimicrobial peptides: potential templates for anticancer agents. Front Med (Lausanne). 2025;12:1548603. https:\/\/doi.org\/10.3389\/fmed.2025.1548603.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"5110_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1021\/acsabm.1c01132","volume":"5","author":"L Yu","year":"2022","unstructured":"Yu L, Li K, Zhang J, Jin H, Saleem A, Song Q, et al. Antimicrobial peptides and macromolecules for combating microbial infections: from agents to interfaces. ACS Appl Bio Mater. 2022;5(2):366\u201393. https:\/\/doi.org\/10.1021\/acsabm.1c01132.","journal-title":"ACS Appl Bio Mater"},{"issue":"3","key":"5110_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1055\/s-0041-1739444","volume":"16","author":"N Nireeksha","year":"2022","unstructured":"Nireeksha N, Gollapalli P, Varma SR, Hegde MN, Kumari NS. Utilizing the potential of antimicrobial peptide LL-37 for combating SARS-COV- 2 viral load in saliva: an in silico analysis. Eur J Dent. 2022;16(3):478\u201387. https:\/\/doi.org\/10.1055\/s-0041-1739444.","journal-title":"Eur J Dent"},{"key":"5110_CR18","doi-asserted-by":"publisher","unstructured":"Aloul KM, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, et al. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.880961.","DOI":"10.3389\/fimmu.2022.880961"},{"key":"5110_CR19","doi-asserted-by":"publisher","unstructured":"Castillo JA, Giraldo DM, Smit JM, Rodenhuis-Zybert IA, Urcuqui-Inchima S. Vitamin D-induced LL-37 modulates innate immune responses of human primary macrophages during DENV-2 infection. Pathog Dis. 2022;80(1). https:\/\/doi.org\/10.1093\/femspd\/ftac014.","DOI":"10.1093\/femspd\/ftac014"},{"issue":"3","key":"5110_CR20","doi-asserted-by":"publisher","first-page":"e17755","DOI":"10.1371\/journal.pone.0017755","volume":"6","author":"P-W Tsai","year":"2011","unstructured":"Tsai P-W, Yang C-Y, Chang H-T, Lan C-Y. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE. 2011;6(3):e17755. https:\/\/doi.org\/10.1371\/journal.pone.0017755.","journal-title":"PLoS ONE"},{"issue":"51","key":"5110_CR21","doi-asserted-by":"publisher","first-page":"52820","DOI":"10.1074\/jbc.C400485200","volume":"279","author":"P Nyberg","year":"2004","unstructured":"Nyberg P, Rasmussen M, Bj\u00f6rck L. Alpha2-macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem. 2004;279(51):52820\u20133. https:\/\/doi.org\/10.1074\/jbc.C400485200.","journal-title":"J Biol Chem"},{"issue":"1","key":"5110_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2958.2002.03146.x","volume":"46","author":"A Schmidtchen","year":"2002","unstructured":"Schmidtchen A, Frick IM, Andersson E, Tapper H, Bj\u00f6rck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol. 2002;46(1):157\u201368. https:\/\/doi.org\/10.1046\/j.1365-2958.2002.03146.x.","journal-title":"Mol Microbiol"},{"key":"5110_CR23","doi-asserted-by":"publisher","first-page":"106363","DOI":"10.1016\/j.ejps.2022.106363","volume":"181","author":"X Luo","year":"2023","unstructured":"Luo X, Chen H, Song Y, Qin Z, Xu L, He N, et al. Advancements, challenges and future perspectives on peptide-based drugs: focus on antimicrobial peptides. Eur J Pharm Sci. 2023;181:106363. https:\/\/doi.org\/10.1016\/j.ejps.2022.106363.","journal-title":"Eur J Pharm Sci"},{"key":"5110_CR24","doi-asserted-by":"publisher","unstructured":"Maron B, Rolff J, Friedman J, Hayouka Z. Antimicrobial Peptide Combination Can Hinder\u00a0Resistance Evolution. Microbiol Spectr. 2022;10(4):e0097322. https:\/\/doi.org\/10.1128\/spectrum.00973-22.","DOI":"10.1128\/spectrum.00973-22"},{"issue":"1","key":"5110_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41597-019-0154-y","volume":"6","author":"X Kang","year":"2019","unstructured":"Kang X, Dong F, Shi C, Liu S, Sun J, Chen J, et al. DRAMP 2.0, an updated data repository of antimicrobial peptides. Sci Data. 2019;6(1):148. https:\/\/doi.org\/10.1038\/s41597-019-0154-y.","journal-title":"Sci Data"},{"issue":"1","key":"5110_CR26","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1038\/s41598-018-29566-5","volume":"8","author":"S Liu","year":"2018","unstructured":"Liu S, Bao J, Lao X, Zheng H. Novel 3D structure based model for activity prediction and design of antimicrobial peptides. Sci Rep. 2018;8(1):11189. https:\/\/doi.org\/10.1038\/s41598-018-29566-5.","journal-title":"Sci Rep"},{"issue":"1","key":"5110_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/psc.2947","volume":"23","author":"S Liu","year":"2017","unstructured":"Liu S, Fan L, Sun J, Lao X, Zheng H. Computational resources and tools for antimicrobial peptides. J Pept Sci. 2017;23(1):4\u201312. https:\/\/doi.org\/10.1002\/psc.2947.","journal-title":"J Pept Sci"},{"key":"5110_CR28","doi-asserted-by":"publisher","first-page":"24482","DOI":"10.1038\/srep24482","volume":"6","author":"L Fan","year":"2016","unstructured":"Fan L, Sun J, Zhou M, Zhou J, Lao X, Zheng H, et al. DRAMP: a comprehensive data repository of antimicrobial peptides. Sci Rep. 2016;6:24482. https:\/\/doi.org\/10.1038\/srep24482.","journal-title":"Sci Rep"},{"issue":"24","key":"5110_CR29","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1016\/j.bmcl.2013.10.031","volume":"23","author":"TK Pham","year":"2013","unstructured":"Pham TK, Kim DH, Lee BJ, Kim YW. Truncated and constrained helical analogs of antimicrobial esculentin-2EM. Bioorg Med Chem Lett. 2013;23(24):6717\u201320. https:\/\/doi.org\/10.1016\/j.bmcl.2013.10.031.","journal-title":"Bioorg Med Chem Lett"},{"issue":"32","key":"5110_CR30","doi-asserted-by":"publisher","first-page":"e2402001","DOI":"10.1002\/adhm.202402001","volume":"13","author":"AG Nowotnick","year":"2024","unstructured":"Nowotnick AG, Xi Z, Jin Z, Khalatbarizamanpoor S, Brauer DS, L\u00f6ffler B, et al. Antimicrobial Biomaterials Based on Physical and Physicochemical Action. Adv Healthc Mater. 2024;13(32):e2402001. https:\/\/doi.org\/10.1002\/adhm.202402001.","journal-title":"Adv Healthc Mater"},{"key":"5110_CR31","doi-asserted-by":"crossref","unstructured":"Musuc AM, Chelu M. Biomaterials-Based Hydrogels for Therapeutic Applications. 1rd ed. Biomaterials in Microencapsulation. Rijeka: IntechOpen; 2024.","DOI":"10.5772\/intechopen.1004826"},{"key":"5110_CR32","doi-asserted-by":"publisher","unstructured":"Lombardi L, Li J, Williams DR. Peptide-Based Biomaterials for Combatting Infections and Improving Drug Delivery. Pharmaceutics. 2024;16(11). https:\/\/doi.org\/10.3390\/pharmaceutics16111468.","DOI":"10.3390\/pharmaceutics16111468"},{"issue":"11","key":"5110_CR33","doi-asserted-by":"publisher","first-page":"e2206602","DOI":"10.1002\/advs.202206602","volume":"10","author":"G Li","year":"2023","unstructured":"Li G, Lai Z, Shan A. Advances of Antimicrobial Peptide-Based Biomaterials for the Treatment of Bacterial Infections. Adv Sci (Weinh). 2023;10(11):e2206602. https:\/\/doi.org\/10.1002\/advs.202206602.","journal-title":"Adv Sci (Weinh)"},{"key":"5110_CR34","doi-asserted-by":"publisher","first-page":"102752","DOI":"10.1016\/j.copbio.2022.102752","volume":"76","author":"L Rojo","year":"2022","unstructured":"Rojo L, Garc\u00eda-Fern\u00e1ndez L, Aguilar MR, V\u00e1zquez-Lasa B. Antimicrobial polymeric biomaterials based on synthetic, nanotechnology, and biotechnological approaches. Curr Opin Biotechnol. 2022;76:102752. https:\/\/doi.org\/10.1016\/j.copbio.2022.102752.","journal-title":"Curr Opin Biotechnol"},{"key":"5110_CR35","doi-asserted-by":"publisher","first-page":"538602","DOI":"10.3389\/fmicb.2020.538602","volume":"11","author":"N Vera-Gonz\u00e1lez","year":"2020","unstructured":"Vera-Gonz\u00e1lez N, Shukla A. Advances in Biomaterials for the Prevention and Disruption of Candida Biofilms. Front Microbiol. 2020;11:538602. https:\/\/doi.org\/10.3389\/fmicb.2020.538602.","journal-title":"Front Microbiol"},{"issue":"1","key":"5110_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/clinpract13010012","volume":"13","author":"P Baindara","year":"2023","unstructured":"Baindara P, Ganguli S, Chakraborty R, Mandal SM. Preventing Respiratory Viral Diseases with Antimicrobial Peptide Master Regulators in the Lung Airway Habitat. Clin Pract. 2023;13(1):125\u201347. https:\/\/doi.org\/10.3390\/clinpract13010012.","journal-title":"Clin Pract"},{"key":"5110_CR37","doi-asserted-by":"publisher","first-page":"e04612021","DOI":"10.1590\/0037-8682-0461-2021","volume":"54","author":"E Tosta","year":"2021","unstructured":"Tosta E. The seven constitutive respiratory defense barriers against SARS-CoV-2 infection. Rev Soc Bras Med Trop. 2021;54:e04612021. https:\/\/doi.org\/10.1590\/0037-8682-0461-2021.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"5110_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1568026615666150703121819","volume":"16","author":"P Dutta","year":"2016","unstructured":"Dutta P, Das S. Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation. Curr Top Med Chem. 2016;16(1):99\u2013129. https:\/\/doi.org\/10.2174\/1568026615666150703121819.","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"5110_CR39","doi-asserted-by":"publisher","first-page":"104305","DOI":"10.1016\/j.drudis.2025.104305","volume":"30","author":"Z Gani","year":"2025","unstructured":"Gani Z, Kumar A, Raje M, Raje CI. Antimicrobial peptides: An alternative strategy to combat antimicrobial resistance. Drug Discov Today. 2025;30(2):104305. https:\/\/doi.org\/10.1016\/j.drudis.2025.104305.","journal-title":"Drug Discov Today"},{"key":"5110_CR40","doi-asserted-by":"publisher","unstructured":"Vanzolini T, Bruschi M, Rinaldi AC, Magnani M, Fraternale A. Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms. Int J Mol Sci. 2022;23(1). https:\/\/doi.org\/10.3390\/ijms23010545.","DOI":"10.3390\/ijms23010545"},{"issue":"8","key":"5110_CR41","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/pmic.201500380","volume":"16","author":"P Shah","year":"2016","unstructured":"Shah P, Hsiao FS, Ho YH, Chen CS. The proteome targets of intracellular targeting antimicrobial peptides. Proteomics. 2016;16(8):1225\u201337. https:\/\/doi.org\/10.1002\/pmic.201500380.","journal-title":"Proteomics"},{"issue":"2","key":"5110_CR42","doi-asserted-by":"publisher","first-page":"e0170224","DOI":"10.1128\/aem.01702-24","volume":"91","author":"P Baindara","year":"2025","unstructured":"Baindara P, Roy D, Boosani CS, Mandal SM, Green JA. AAV-based gene delivery of antimicrobial peptides to combat drug-resistant pathogens. Appl Environ Microbiol. 2025;91(2):e0170224. https:\/\/doi.org\/10.1128\/aem.01702-24.","journal-title":"Appl Environ Microbiol"},{"key":"5110_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13104-015-1836-y","volume":"9","author":"JL Harcourt","year":"2016","unstructured":"Harcourt JL, McDonald M, Svoboda P, Pohl J, Tatti K, Haynes LM. Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells. BMC Res Notes. 2016;9:11. https:\/\/doi.org\/10.1186\/s13104-015-1836-y.","journal-title":"BMC Res Notes"},{"key":"5110_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1146\/annurev.physiol.64.081501.134340","volume":"64","author":"BC Schutte","year":"2002","unstructured":"Schutte BC, McCray PB Jr. [beta]-defensins in lung host defense. Annu Rev Physiol. 2002;64:709\u201348. https:\/\/doi.org\/10.1146\/annurev.physiol.64.081501.134340.","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"5110_CR45","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11095-022-03379-8","volume":"40","author":"J Li","year":"2023","unstructured":"Li J, Zheng H, Leung SSY. Pulmonary delivery of emerging antibacterials for bacterial lung infections treatment. Pharm Res. 2023;40(5):1057\u201372. https:\/\/doi.org\/10.1007\/s11095-022-03379-8.","journal-title":"Pharm Res"},{"issue":"16","key":"5110_CR46","doi-asserted-by":"publisher","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","volume":"95","author":"R Bals","year":"1998","unstructured":"Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A. 1998;95(16):9541\u20136. https:\/\/doi.org\/10.1073\/pnas.95.16.9541.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1 Pt 1","key":"5110_CR47","doi-asserted-by":"publisher","first-page":"L60","DOI":"10.1152\/ajplung.1992.263.1.L60","volume":"263","author":"E Crouch","year":"1992","unstructured":"Crouch E, Parghi D, Kuan SF, Persson A. Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am J Physiol. 1992;263(1 Pt 1):L60\u20136. https:\/\/doi.org\/10.1152\/ajplung.1992.263.1.L60.","journal-title":"Am J Physiol"},{"issue":"4","key":"5110_CR48","doi-asserted-by":"publisher","first-page":"L750","DOI":"10.1152\/ajplung.00326.2003","volume":"286","author":"RF Dubin","year":"2004","unstructured":"Dubin RF, Robinson SK, Widdicombe JH. Secretion of lactoferrin and lysozyme by cultures of human airway epithelium. Am J Physiol Lung Cell Mol Physiol. 2004;286(4):L750\u20135. https:\/\/doi.org\/10.1152\/ajplung.00326.2003.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"5110_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/bst0300111","volume":"30","author":"JM Sallenave","year":"2002","unstructured":"Sallenave JM. Antimicrobial activity of antiproteinases. Biochem Soc Trans. 2002;30(2):111\u20135.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"5110_CR50","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1089\/10799900260286650","volume":"22","author":"J Lindbom","year":"2002","unstructured":"Lindbom J, Ljungman AG, Lindahl M, Tagesson C. Increased gene expression of novel cytosolic and secretory phospholipase A(2) types in human airway epithelial cells induced by tumor necrosis factor-alpha and IFN-gamma. J Interferon Cytokine Res. 2002;22(9):947\u201355. https:\/\/doi.org\/10.1089\/10799900260286650.","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"5110_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/bf00249221","volume":"214","author":"TG Christensen","year":"1981","unstructured":"Christensen TG, Blanchard GC, Nolley G, Hayes JA. Ultrastructural localization of endogenous peroxidase in the lower respiratory tract of the guinea pig. Cell Tissue Res. 1981;214(2):407\u201315. https:\/\/doi.org\/10.1007\/bf00249221.","journal-title":"Cell Tissue Res"},{"issue":"5","key":"5110_CR52","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1165\/rcmb.2002-0272OC","volume":"29","author":"TD Starner","year":"2003","unstructured":"Starner TD, Barker CK, Jia HP, Kang Y, McCray PB Jr. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol. 2003;29(5):627\u201333. https:\/\/doi.org\/10.1165\/rcmb.2002-0272OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"17","key":"5110_CR53","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/pola.29078","volume":"56","author":"S Zaccaria","year":"2018","unstructured":"Zaccaria S, van Gaal RC, Riool M, Zaat SAJ, Dankers PYW. Antimicrobial peptide modification of biomaterials using supramolecular additives. J Polym Sci A Polym Chem. 2018;56(17):1926\u201334. https:\/\/doi.org\/10.1002\/pola.29078.","journal-title":"J Polym Sci A Polym Chem"},{"key":"5110_CR54","doi-asserted-by":"publisher","unstructured":"Riool M, de Breij A, Drijfhout JW, Nibbering PH, Zaat SAJ. Antimicrobial Peptides in Biomedical Device Manufacturing. Front Chem. 2017;5. https:\/\/doi.org\/10.3389\/fchem.2017.00063.","DOI":"10.3389\/fchem.2017.00063"},{"issue":"9","key":"5110_CR55","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/antibiotics13090794","volume":"13","author":"KH Min","year":"2024","unstructured":"Min KH, Kim KH, Ki M-R, Pack SP. Antimicrobial peptides and their biomedical applications: a review. Antibiotics. 2024;13(9):794.","journal-title":"Antibiotics"},{"key":"5110_CR56","doi-asserted-by":"publisher","unstructured":"Huan Y, Kong Q, Mou H, Yi H. Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Frontiers in Microbiology. 2020;11. https:\/\/doi.org\/10.3389\/fmicb.2020.582779.","DOI":"10.3389\/fmicb.2020.582779"},{"key":"5110_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.mie.2021.09.006","volume":"663","author":"G Wang","year":"2022","unstructured":"Wang G. Unifying the classification of antimicrobial peptides in the antimicrobial peptide database. Methods Enzymol. 2022;663:1\u201318. https:\/\/doi.org\/10.1016\/bs.mie.2021.09.006.","journal-title":"Methods Enzymol"},{"key":"5110_CR58","doi-asserted-by":"publisher","unstructured":"Wang G. Bioinformatic Analysis of 1000 Amphibian Antimicrobial Peptides Uncovers Multiple Length-Dependent Correlations for Peptide Design and Prediction. Antibiotics (Basel). 2020;9(8). https:\/\/doi.org\/10.3390\/antibiotics9080491.","DOI":"10.3390\/antibiotics9080491"},{"key":"5110_CR59","doi-asserted-by":"publisher","unstructured":"Liu Y, Shi D, Wang J, Chen X, Zhou M, Xi X, et al. A Novel Amphibian Antimicrobial Peptide, Phylloseptin-PV1, Exhibits Effective Anti-staphylococcal Activity Without Inducing Either Hepatic or Renal Toxicity in Mice. Front Microbiol. 2020;11. https:\/\/doi.org\/10.3389\/fmicb.2020.565158.","DOI":"10.3389\/fmicb.2020.565158"},{"issue":"21","key":"5110_CR60","doi-asserted-by":"publisher","first-page":"21875","DOI":"10.1021\/acsomega.5c01923","volume":"10","author":"CA Ezema","year":"2025","unstructured":"Ezema CA, Shibagaki M, Kikukawa T, Arai T, Aizawa T. Amphibian-derived Cathelicidin-DM and Cathelicidin-BG: recombinant overexpression in Escherichia coli and comparison of their structures and antimicrobial activities. ACS Omega. 2025;10(21):21875\u201388. https:\/\/doi.org\/10.1021\/acsomega.5c01923.","journal-title":"ACS Omega"},{"key":"5110_CR61","doi-asserted-by":"publisher","unstructured":"Sahoo A, Swain SS, Behera A, Sahoo G, Mahapatra PK, Panda SK. Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review. Front Microbiol. 2021;12. https:\/\/doi.org\/10.3389\/fmicb.2021.661195.","DOI":"10.3389\/fmicb.2021.661195"},{"issue":"13","key":"5110_CR62","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1007\/s00253-014-5792-6","volume":"98","author":"HY Yi","year":"2014","unstructured":"Yi HY, Chowdhury M, Huang YD, Yu XQ. Insect antimicrobial peptides and their applications. Appl Microbiol Biotechnol. 2014;98(13):5807\u201322. https:\/\/doi.org\/10.1007\/s00253-014-5792-6.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"5110_CR63","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.3390\/ijms24065753","volume":"24","author":"S St\u0105czek","year":"2023","unstructured":"St\u0105czek S, Cytry\u0144ska M, Zdybicka-Barabas A. Unraveling the role of antimicrobial peptides in insects. Int J Mol Sci. 2023;24(6):5753.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"5110_CR64","doi-asserted-by":"publisher","first-page":"10788","DOI":"10.3390\/ijms251910788","volume":"25","author":"R Mihaylova-Garnizova","year":"2024","unstructured":"Mihaylova-Garnizova R, Davidova S, Hodzhev Y, Satchanska G. Antimicrobial peptides derived from bacteria: classification, sources, and mechanism of action against multidrug-resistant bacteria. Int J Mol Sci. 2024;25(19):10788.","journal-title":"Int J Mol Sci"},{"key":"5110_CR65","doi-asserted-by":"publisher","first-page":"1125635","DOI":"10.3389\/fimmu.2023.1125635","volume":"14","author":"AA Joshi","year":"2023","unstructured":"Joshi AA, Vocanson M, Nicolas JF, Wolf P, Patra V. Microbial derived antimicrobial peptides as potential therapeutics in atopic dermatitis. Front Immunol. 2023;14:1125635. https:\/\/doi.org\/10.3389\/fimmu.2023.1125635.","journal-title":"Front Immunol"},{"key":"5110_CR66","doi-asserted-by":"publisher","unstructured":"Mishra AK, Choi J, Moon E, Baek KH. Tryptophan-Rich and Proline-Rich Antimicrobial Peptides. Molecules. 2018;23(4). https:\/\/doi.org\/10.3390\/molecules23040815.","DOI":"10.3390\/molecules23040815"},{"issue":"24","key":"5110_CR67","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.3390\/molecules29245864","volume":"29","author":"S St\u0105czek","year":"2024","unstructured":"St\u0105czek S, Kunat-Budzy\u0144ska M, Cytry\u0144ska M, Zdybicka-Barabas A. Proline-rich antimicrobial peptides from invertebrates. Molecules. 2024;29(24):5864.","journal-title":"Molecules"},{"key":"5110_CR68","doi-asserted-by":"publisher","first-page":"108570","DOI":"10.1016\/j.biotechadv.2025.108570","volume":"81","author":"R Yang","year":"2025","unstructured":"Yang R, Ma X, Peng F, Wen J, Allahou LW, Williams GR, et al. Advances in antimicrobial peptides: from mechanistic insights to chemical modifications. Biotechnol Adv. 2025;81:108570. https:\/\/doi.org\/10.1016\/j.biotechadv.2025.108570.","journal-title":"Biotechnol Adv"},{"issue":"5","key":"5110_CR69","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/agronomy15051113","volume":"15","author":"D Sun","year":"2025","unstructured":"Sun D, Jia Z, Zhu J, Liu J, Chen Y, Xu Z, et al. Antimicrobial Peptides and Their Potential Applications in Plant Protection. Agronomy. 2025;15(5):1113.","journal-title":"Agronomy"},{"key":"5110_CR70","doi-asserted-by":"publisher","unstructured":"Decker AP, Mechesso AF, Wang G. Expanding the Landscape of Amino Acid-Rich Antimicrobial Peptides: Definition, Deployment in Nature, Implications for Peptide Design and Therapeutic Potential. Int J Mol Sci. 2022;23(21). https:\/\/doi.org\/10.3390\/ijms232112874.","DOI":"10.3390\/ijms232112874"},{"issue":"11","key":"5110_CR71","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/fermentation10110540","volume":"10","author":"X Ma","year":"2024","unstructured":"Ma X, Wang Q, Ren K, Xu T, Zhang Z, Xu M, et al. A review of antimicrobial peptides: structure, mechanism of action, and molecular optimization strategies. Fermentation. 2024;10(11):540.","journal-title":"Fermentation"},{"key":"5110_CR72","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.biopha.2017.09.042","volume":"95","author":"S Patel","year":"2017","unstructured":"Patel S, Akhtar N. Antimicrobial peptides (AMPs): the quintessential \u2018offense and defense\u2019 molecules are more than antimicrobials. Biomed Pharmacother. 2017;95:1276\u201383. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.042.","journal-title":"Biomed Pharmacother"},{"key":"5110_CR73","doi-asserted-by":"publisher","unstructured":"Su Z, Yu H, Lv T, Chen Q, Luo H, Zhang H. Progress in the classification, optimization, activity, and application of antimicrobial peptides. Front Microbiol. 2025;16. https:\/\/doi.org\/10.3389\/fmicb.2025.1582863.","DOI":"10.3389\/fmicb.2025.1582863"},{"issue":"4","key":"5110_CR74","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1097\/MS9.0000000000003106","volume":"87","author":"S Shriwastav","year":"2025","unstructured":"Shriwastav S, Kaur N, Hassan M, Ahmed Mohammed S, Chauhan S, Mittal D, et al. Antimicrobial peptides: a promising frontier to combat antibiotic resistant pathogens. Ann Med Surg (Lond). 2025;87(4):2118\u201332. https:\/\/doi.org\/10.1097\/MS9.0000000000003106.","journal-title":"Ann Med Surg (Lond)"},{"key":"5110_CR75","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bioactmat.2025.02.008","volume":"49","author":"KA Rahaman","year":"2025","unstructured":"Rahaman KA, Mukim MSI, Hasan ML, Kim H, Pan CH, Kwon OS, et al. Protein to biomaterials: unraveling the antiviral and proangiogenic activities of Ac-T\u03b2(1-17) peptide, a Thymosin \u03b24 metabolite, and its implications in peptide-scaffold preparation. Bioact Mater. 2025;49:437\u201355. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.02.008.","journal-title":"Bioact Mater"},{"key":"5110_CR76","doi-asserted-by":"publisher","unstructured":"Oshiro KGN, Rodrigues G, Monges BED, Cardoso MH, Franco OL. Bioactive Peptides Against Fungal Biofilms. Front Microbiol. 2019;10. https:\/\/doi.org\/10.3389\/fmicb.2019.02169.","DOI":"10.3389\/fmicb.2019.02169"},{"issue":"10","key":"5110_CR77","doi-asserted-by":"publisher","first-page":"eads8932","DOI":"10.1126\/sciadv.ads8932","volume":"11","author":"J Wang","year":"2025","unstructured":"Wang J, Feng J, Kang Y, Pan P, Ge J, Wang Y, et al. Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model. Sci Adv. 2025;11(10):eads8932. https:\/\/doi.org\/10.1126\/sciadv.ads8932.","journal-title":"Sci Adv"},{"key":"5110_CR78","doi-asserted-by":"publisher","first-page":"101958","DOI":"10.1016\/j.mtbio.2025.101958","volume":"33","author":"DA B\u00f6hner","year":"2025","unstructured":"B\u00f6hner DA, M\u00f6rl K, Beck-Sickinger AG. Bio-inspired biomaterial coating for enzyme responsive release of antimicrobial peptides. Mater Today Bio. 2025;33:101958. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101958.","journal-title":"Mater Today Bio"},{"issue":"6","key":"5110_CR79","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/psc.70025","volume":"31","author":"D Simonovic","year":"2025","unstructured":"Simonovic D, Dey H, Johansen N, Anderssen T, Hansen IKO, Devold H, et al. Antimicrobial activity of short analogues of the marine peptide EeCentrocin 1: synthesis of lipopeptides and head-to-tail cyclic peptides and mechanism of action studies. J Pept Sci. 2025;31(6):e70025. https:\/\/doi.org\/10.1002\/psc.70025.","journal-title":"J Pept Sci"},{"key":"5110_CR80","doi-asserted-by":"publisher","unstructured":"Xia Z, Xie L, Li B, Lv X, Zhang H, Cao Z. Antimicrobial Potential of Scorpion-Venom-Derived Peptides. Molecules. 2024;29(21). https:\/\/doi.org\/10.3390\/molecules29215080.","DOI":"10.3390\/molecules29215080"},{"key":"5110_CR81","doi-asserted-by":"publisher","unstructured":"Gong Y, Xue Q, Li J, Zhang S. Antifungal peptides from living organisms. Frontiers in Microbiology. 2024;15. https:\/\/doi.org\/10.3389\/fmicb.2024.1511461.","DOI":"10.3389\/fmicb.2024.1511461"},{"issue":"12","key":"5110_CR82","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s40121-023-00889-9","volume":"12","author":"CG Freitas","year":"2023","unstructured":"Freitas CG, Felipe MS. Candida albicans and antifungal peptides. Infect Dis Ther. 2023;12(12):2631\u201348. https:\/\/doi.org\/10.1007\/s40121-023-00889-9.","journal-title":"Infect Dis Ther"},{"key":"5110_CR83","doi-asserted-by":"publisher","unstructured":"Brice DC, Diamond G. Antiviral Activities of Human Host Defense Peptides. Curr Med Chem 2020;27(9):1420\u201343. https:\/\/doi.org\/10.2174\/0929867326666190805151654.","DOI":"10.2174\/0929867326666190805151654"},{"key":"5110_CR84","doi-asserted-by":"publisher","unstructured":"Hsieh IN, Hartshorn KL. The Role of Antimicrobial Peptides in Influenza Virus Infection and Thei Potential as Antiviral and Immunomodulatory Therapy. Pharmaceuticals (Basel). 2016;9(3). https:\/\/doi.org\/10.3390\/ph9030053.","DOI":"10.3390\/ph9030053."},{"key":"5110_CR85","doi-asserted-by":"publisher","unstructured":"Uwamahoro H, Collier WE, Nashar TO, Jaynes JM, Mortley DG, Davis CG, et al. Natural and Designed Cyclic Peptides as Potential Antiviral Drugs to Combat Future Coronavirus Outbreaks. Molecules. 2025;30(8). https:\/\/doi.org\/10.3390\/molecules30081651.","DOI":"10.3390\/molecules30081651"},{"key":"5110_CR86","doi-asserted-by":"publisher","unstructured":"Owliaee I, Khaledian M, Shojaeian A, Madanchi H, Yarani R, Boroujeni AK, et al. Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions. Probiotics Antimicrob Proteins. 2025. https:\/\/doi.org\/10.1007\/s12602-024-10430-0.","DOI":"10.1007\/s12602-024-10430-0"},{"key":"5110_CR87","doi-asserted-by":"publisher","unstructured":"Nawaz M, Huiyuan Y, Akhtar F, Tianyue M, Zheng H. Deep learning in the discovery of antiviral peptides and peptidomimetics: databases and prediction tools. Mol Divers. 2025. https:\/\/doi.org\/10.1007\/s11030-025-11173-y.","DOI":"10.1007\/s11030-025-11173-y"},{"issue":"2","key":"5110_CR88","doi-asserted-by":"publisher","first-page":"e3541","DOI":"10.1002\/psc.3541","volume":"30","author":"M Quagliata","year":"2024","unstructured":"Quagliata M, Papini AM, Rovero P. Chemically modified antiviral peptides against SARS-CoV-2. J Pept Sci. 2024;30(2):e3541. https:\/\/doi.org\/10.1002\/psc.3541.","journal-title":"J Pept Sci"},{"issue":"27","key":"5110_CR89","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.2174\/1381612829666230904150823","volume":"29","author":"N Mohtasham","year":"2023","unstructured":"Mohtasham N, Bargi R, Farshbaf A, Shahri MV, Hesari KK, Mohajertehran F. Salivary antiviral and antibacterial properties in the encounter of SARS-CoV-2. Curr Pharm Des. 2023;29(27):2140\u20138. https:\/\/doi.org\/10.2174\/1381612829666230904150823.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"5110_CR90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s44370-024-00006-5","volume":"2","author":"A Qureshi","year":"2025","unstructured":"Qureshi A. A review on current status of antiviral peptides. Discov Viruses. 2025;2(1):3. https:\/\/doi.org\/10.1007\/s44370-024-00006-5.","journal-title":"Discov Viruses"},{"key":"5110_CR91","doi-asserted-by":"publisher","first-page":"9898241","DOI":"10.34133\/2022\/9898241","volume":"2022","author":"YJ Lee","year":"2022","unstructured":"Lee YJ, Shirkey JD, Park J, Bisht K, Cowan AJ. An overview of antiviral peptides and rational biodesign considerations. Biodes Res. 2022;2022:9898241. https:\/\/doi.org\/10.34133\/2022\/9898241.","journal-title":"Biodes Res"},{"key":"5110_CR92","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3389\/fimmu.2020.02030","volume":"11","author":"M Feng","year":"2020","unstructured":"Feng M, Fei S, Xia J, Labropoulou V, Swevers L, Sun J. Antimicrobial peptides as potential antiviral factors in insect antiviral immune response. Front Immunol. 2020;11:2030. https:\/\/doi.org\/10.3389\/fimmu.2020.02030.","journal-title":"Front Immunol"},{"key":"5110_CR93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/bs.vh.2021.06.008","volume":"117","author":"CL Poh","year":"2021","unstructured":"Poh CL, Lalani S. Strategies to identify and develop antiviral peptides. Vitam Horm. 2021;117:17\u201346. https:\/\/doi.org\/10.1016\/bs.vh.2021.06.008.","journal-title":"Vitam Horm"},{"issue":"1","key":"5110_CR94","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s44259-025-00125-z","volume":"3","author":"DZH Aw","year":"2025","unstructured":"Aw DZH, Zhang DX, Vignuzzi M. Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals. npj Antimicrob Resist. 2025;3(1):54. https:\/\/doi.org\/10.1038\/s44259-025-00125-z.","journal-title":"npj Antimicrob Resist"},{"issue":"1","key":"5110_CR95","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12859-024-05726-5","volume":"25","author":"S Akbar","year":"2024","unstructured":"Akbar S, Raza A, Zou Q. Deepstacked-AVPs: predicting antiviral peptides using tri-segment evolutionary profile and word embedding based multi-perspective features with deep stacking model. BMC Bioinformatics. 2024;25(1):102. https:\/\/doi.org\/10.1186\/s12859-024-05726-5.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"5110_CR96","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/v2122696","volume":"2","author":"S Margeridon-Thermet","year":"2010","unstructured":"Margeridon-Thermet S, Shafer RW. Comparison of the mechanisms of drug resistance among HIV, Hepatitis B, and Hepatitis C. Viruses. 2010;2(12):2696\u2013739. https:\/\/doi.org\/10.3390\/v2122696.","journal-title":"Viruses"},{"issue":"6","key":"5110_CR97","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1053\/j.gastro.2011.12.060","volume":"142","author":"JM Pawlotsky","year":"2012","unstructured":"Pawlotsky JM. Is Hepatitis virus resistance to antiviral drugs a threat? Gastroenterology. 2012;142(6):1369\u201372. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.060.","journal-title":"Gastroenterology"},{"issue":"4","key":"5110_CR98","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/idr15040046","volume":"15","author":"M Garvey","year":"2023","unstructured":"Garvey M. Antimicrobial peptides demonstrate activity against resistant bacterial pathogens. Infect Dis Rep. 2023;15(4):454\u201369. https:\/\/doi.org\/10.3390\/idr15040046.","journal-title":"Infect Dis Rep"},{"issue":"4","key":"5110_CR99","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/lam.13270","volume":"70","author":"H Tahmasebi","year":"2020","unstructured":"Tahmasebi H, Dehbashi S, Arabestani MR. New approach to identify colistin-resistant Pseudomonas aeruginosa by high-resolution melting curve analysis assay. Lett Appl Microbiol. 2020;70(4):290\u20139. https:\/\/doi.org\/10.1111\/lam.13270.","journal-title":"Lett Appl Microbiol"},{"issue":"7","key":"5110_CR100","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/microorganisms12071259","volume":"12","author":"L Tajer","year":"2024","unstructured":"Tajer L, Paillart J-C, Dib H, Sabatier J-M, Fajloun Z, Abi Khattar Z. Molecular mechanisms of bacterial resistance to antimicrobial peptides in the modern era: an updated review. Microorganisms. 2024;12(7):1259.","journal-title":"Microorganisms"},{"key":"5110_CR101","doi-asserted-by":"publisher","first-page":"593215","DOI":"10.3389\/fmicb.2020.593215","volume":"11","author":"L Assoni","year":"2020","unstructured":"Assoni L, Milani B, Carvalho MR, Nepomuceno LN, Waz NT, Guerra MES, et al. Resistance mechanisms to antimicrobial peptides in Gram-positive bacteria. Front Microbiol. 2020;11:593215. https:\/\/doi.org\/10.3389\/fmicb.2020.593215.","journal-title":"Front Microbiol"},{"key":"5110_CR102","doi-asserted-by":"publisher","unstructured":"Joo HS, Fu CI, Otto M. Bacterial strategies of resistance to antimicrobial peptides. Philos Trans R Soc Lond B Biol Sci. 2016;371(1695). https:\/\/doi.org\/10.1098\/rstb.2015.0292.","DOI":"10.1098\/rstb.2015.0292"},{"issue":"7","key":"5110_CR103","doi-asserted-by":"publisher","first-page":"e3002692","DOI":"10.1371\/journal.pbio.3002692","volume":"22","author":"B Antunes","year":"2024","unstructured":"Antunes B, Zanchi C, Johnston PR, Maron B, Witzany C, Regoes RR, et al. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures. PLoS Biol. 2024;22(7):e3002692. https:\/\/doi.org\/10.1371\/journal.pbio.3002692.","journal-title":"PLoS Biol"},{"issue":"1","key":"5110_CR104","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","volume":"1","author":"Y Lee","year":"2023","unstructured":"Lee Y, Robbins N, Cowen LE. Molecular mechanisms governing antifungal drug resistance. NPJ Antimicrob Resist. 2023;1(1):5. https:\/\/doi.org\/10.1038\/s44259-023-00007-2.","journal-title":"NPJ Antimicrob Resist"},{"issue":"11","key":"5110_CR105","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.4014\/jmb.1807.07002","volume":"28","author":"H Lee","year":"2018","unstructured":"Lee H, Lee DG. Novel approaches for efficient antifungal drug action. J Microbiol Biotechnol. 2018;28(11):1771\u201381. https:\/\/doi.org\/10.4014\/jmb.1807.07002.","journal-title":"J Microbiol Biotechnol"},{"key":"5110_CR106","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2014.00202","volume":"5","author":"R Prasad","year":"2014","unstructured":"Prasad R, Rawal MK. Efflux pump proteins in antifungal resistance. Front Pharmacol. 2014;5:202. https:\/\/doi.org\/10.3389\/fphar.2014.00202.","journal-title":"Front Pharmacol"},{"issue":"8","key":"5110_CR107","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2174\/138920111796117265","volume":"12","author":"AP Desbois","year":"2011","unstructured":"Desbois AP, Tsch\u00f6rner D, Coote PJ. Survey of small antifungal peptides with chemotherapeutic potential. Curr Pharm Biotechnol. 2011;12(8):1263\u201391. https:\/\/doi.org\/10.2174\/138920111796117265.","journal-title":"Curr Pharm Biotechnol"},{"key":"5110_CR108","unstructured":"Jensen RH. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Dan Med J. 2016;63(10)."},{"key":"5110_CR109","doi-asserted-by":"publisher","unstructured":"Lemos ASO, Flor\u00eancio JR, Pinto NCC, Campos LM, Silva TP, Grazul RM, et al. Antifungal Activity of\u00a0the Natural Coumarin Scopoletin Against Planktonic Cells and Biofilms From a Multidru\u00a0Resistant Candida tropicalis Strain. Front Microbiol. 2020;11:1525. https:\/\/doi.org\/10.3389\/fmicb.2020.01525.","DOI":"10.3389\/fmicb.2020.01525."},{"key":"5110_CR110","doi-asserted-by":"publisher","unstructured":"Delattin N, Brucker K, Cremer K, Cammue BP, Thevissen K. Antimicrobial Peptides as a Strategy to Combat Fungal Biofilms. Curr Top Med Chem. 2017;17(5):604\u201312. https:\/\/doi.org\/10.2174\/1568026616666160713142228.","DOI":"10.2174\/1568026616666160713142228"},{"key":"5110_CR111","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez de Ullivarri M, Arbulu S, Garcia-Gutierrez E, Cotter PD. Antifungal Peptides as Therapeutic Agents. Frontiers in Cellular and Infection Microbiology. 2020;10:2020. https:\/\/doi.org\/10.3389\/fcimb.2020.00105.","DOI":"10.3389\/fcimb.2020.00105"},{"key":"5110_CR112","doi-asserted-by":"publisher","unstructured":"Mamouei Z, Alqarihi A, Singh S, Xu S, Mansour MK, Ibrahim AS, et al. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens. mSphere. 2018;3(5). https:\/\/doi.org\/10.1128\/mSphere.00539-18.","DOI":"10.1128\/mSphere.00539-18"},{"key":"5110_CR113","doi-asserted-by":"publisher","unstructured":"Pimienta DA, Cruz Mosquera FE, Palacios Velasco I, Giraldo Rodas M, O\u00f1ate-Garz\u00f3n J, Liscano Y. Specific Focus on Antifungal Peptides against Azole Resistant Aspergillus fumigatus: Current Status, Challenges, and Future Perspectives. J Fungi (Basel). 2022;9(1). https:\/\/doi.org\/10.3390\/jof9010042.","DOI":"10.3390\/jof9010042"},{"key":"5110_CR114","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3389\/fmicb.2018.00855","volume":"9","author":"LS Biswaro","year":"2018","unstructured":"Biswaro LS, da Costa Sousa MG, Rezende TMB, Dias SC, Franco OL. Antimicrobial peptides and nanotechnology, recent advances and challenges. Front Microbiol. 2018;9:855. https:\/\/doi.org\/10.3389\/fmicb.2018.00855.","journal-title":"Front Microbiol"},{"issue":"1","key":"5110_CR115","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s12672-025-03855-8","volume":"16","author":"A Bahar","year":"2025","unstructured":"Bahar A, Porbaran M, Khazaei M, Tahmasebi H. Antimicrobial peptides for anticancer and antiviral therapy: last promising update. Discov Oncol. 2025;16(1):1991. https:\/\/doi.org\/10.1007\/s12672-025-03855-8.","journal-title":"Discov Oncol"},{"issue":"4","key":"5110_CR116","first-page":"445","volume":"95","author":"IE Mba","year":"2022","unstructured":"Mba IE, Nweze EI. Antimicrobial peptides therapy: an emerging alternative for treating drug-resistant bacteria. Yale J Biol Med. 2022;95(4):445\u201363.","journal-title":"Yale J Biol Med"},{"key":"5110_CR117","doi-asserted-by":"publisher","unstructured":"Calibio Giraldo IY, Ghilini F, Prieto E, D\u00edaz C, Schilardi PL. Anti-Biofouling Albumin Amyloid Coatings Enable Vancomycin-Mediated Bacterial Eradication on Medical Tubing. bioRxiv. 2025:2025.09.14.676079. https:\/\/doi.org\/10.1101\/2025.09.14.676079.","DOI":"10.1101\/2025.09.14.676079"},{"key":"5110_CR118","doi-asserted-by":"publisher","unstructured":"Patrulea V, Borchard G, Jordan O. An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections. Pharmaceutics. 2020;12(9). https:\/\/doi.org\/10.3390\/pharmaceutics12090840.","DOI":"10.3390\/pharmaceutics12090840"},{"issue":"6","key":"5110_CR119","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14712598.2017.1315402","volume":"17","author":"JM Sierra","year":"2017","unstructured":"Sierra JM, Fust\u00e9 E, Rabanal F, Vinuesa T, Vi\u00f1as M. An overview of antimicrobial peptides and the latest advances in their development. Expert Opin Biol Ther. 2017;17(6):663\u201376. https:\/\/doi.org\/10.1080\/14712598.2017.1315402.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"5110_CR120","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/RPS.RPS_75_24","volume":"20","author":"R Ghavimi","year":"2025","unstructured":"Ghavimi R, Mahmoudi S, Mohammadi M, Khodamoradi E, Jahanian-Najafabadi A. Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment. Res Pharm Sci. 2025;20(2):165\u201387. https:\/\/doi.org\/10.4103\/RPS.RPS_75_24.","journal-title":"Res Pharm Sci"},{"key":"5110_CR121","doi-asserted-by":"publisher","unstructured":"Tolos Vasii AM, Moisa C, Dochia M, Popa C, Copolovici L, Copolovici DM. Anticancer Potential of Antimicrobial Peptides: Focus on Buforins. Polymers (Basel). 2024;16(6). https:\/\/doi.org\/10.3390\/polym16060728.","DOI":"10.3390\/polym16060728"},{"issue":"3","key":"5110_CR122","doi-asserted-by":"publisher","first-page":"184260","DOI":"10.1016\/j.bbamem.2023.184260","volume":"1866","author":"SK Straus","year":"2024","unstructured":"Straus SK. Tryptophan- and arginine-rich antimicrobial peptides: anti-infectives with great potential. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2024;1866(3):184260. https:\/\/doi.org\/10.1016\/j.bbamem.2023.184260.","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"1","key":"5110_CR123","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41578-021-00362-4","volume":"7","author":"PP Kalelkar","year":"2022","unstructured":"Kalelkar PP, Riddick M, Garc\u00eda AJ. Biomaterial-based delivery of antimicrobial therapies for the treatment of bacterial infections. Nat Rev Mater. 2022;7(1):39\u201354. https:\/\/doi.org\/10.1038\/s41578-021-00362-4.","journal-title":"Nat Rev Mater"},{"issue":"6","key":"5110_CR124","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/cbdd.13031","volume":"90","author":"U Piotrowska","year":"2017","unstructured":"Piotrowska U, Sobczak M, Oledzka E. Current state of a dual behaviour of antimicrobial peptides-therapeutic agents and promising delivery vectors. Chem Biol Drug Des. 2017;90(6):1079\u201393. https:\/\/doi.org\/10.1111\/cbdd.13031.","journal-title":"Chem Biol Drug Des"},{"key":"5110_CR125","doi-asserted-by":"publisher","first-page":"114066","DOI":"10.1016\/j.addr.2021.114066","volume":"180","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chang RYK, Britton WJ, Chan H-K. Advances in the development of antimicrobial peptides and proteins for inhaled therapy. Adv Drug Deliv Rev. 2022;180:114066. https:\/\/doi.org\/10.1016\/j.addr.2021.114066.","journal-title":"Adv Drug Deliv Rev"},{"key":"5110_CR126","doi-asserted-by":"crossref","unstructured":"Shi Y, Wareham DW, Phee LM, Azevedo HS. Self-assembled Peptide Nanostructures for Antibacterial Applications. In: Guler MO, editor. Peptide-based Biomaterials. The Royal Society of Chemistry; 2020. p. 0.","DOI":"10.1039\/9781839161148-00395"},{"key":"5110_CR127","doi-asserted-by":"publisher","first-page":"809584","DOI":"10.3389\/fchem.2021.809584","volume":"9","author":"M Wu","year":"2021","unstructured":"Wu M, He S, Tang H, Hu H, Shi Y. Molecular engineering of Polymyxin B for imaging and treatment of bacterial infections. Front Chem. 2021;9:809584. https:\/\/doi.org\/10.3389\/fchem.2021.809584.","journal-title":"Front Chem"},{"issue":"31","key":"5110_CR128","doi-asserted-by":"publisher","first-page":"e2402453","DOI":"10.1002\/adhm.202402453","volume":"13","author":"M Wu","year":"2024","unstructured":"Wu M, Li Y, Shen H, Zhang Y, Cong W, Hu X, et al. A \u03b2-Lactamase responsive peptide inhibits MRSA infection through self-assembled nanonet. Adv Healthc Mater. 2024;13(31):e2402453. https:\/\/doi.org\/10.1002\/adhm.202402453.","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"5110_CR129","doi-asserted-by":"publisher","first-page":"e73659","DOI":"10.1371\/journal.pone.0073659","volume":"8","author":"SM Currie","year":"2013","unstructured":"Currie SM, Findlay EG, McHugh BJ, Mackellar A, Man T, Macmillan D, et al. The human cathelicidin LL-37 has antiviral activity against Respiratory Syncytial Virus. PLoS ONE. 2013;8(8):e73659. https:\/\/doi.org\/10.1371\/journal.pone.0073659.","journal-title":"PLoS ONE"},{"issue":"22","key":"5110_CR130","doi-asserted-by":"publisher","first-page":"e40121","DOI":"10.1016\/j.heliyon.2024.e40121","volume":"10","author":"M Neghabi Hajigha","year":"2024","unstructured":"Neghabi Hajigha M, Hajikhani B, Vaezjalali M, Samadi Kafil H, Kazemzadeh Anari R, Goudarzi M. Antiviral and antibacterial peptides: mechanisms of action. Heliyon. 2024;10(22):e40121. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40121.","journal-title":"Heliyon"},{"issue":"1","key":"5110_CR131","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12967-024-05378-2","volume":"22","author":"V Ferrucci","year":"2024","unstructured":"Ferrucci V, Miceli M, Pagliuca C, Bianco O, Castaldo L, Izzo L, et al. Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties. J Transl Med. 2024;22(1):574. https:\/\/doi.org\/10.1186\/s12967-024-05378-2.","journal-title":"J Transl Med"},{"key":"5110_CR132","doi-asserted-by":"publisher","unstructured":"Riool M, Patrulea V, Monteiro C. Antimicrobial Peptide-Polymer Conjugates. Pharmaceutics. 2022;14(10). https:\/\/doi.org\/10.3390\/pharmaceutics14102171.","DOI":"10.3390\/pharmaceutics14102171"},{"issue":"9","key":"5110_CR133","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2217\/fmb.09.87","volume":"4","author":"AF Gombart","year":"2009","unstructured":"Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009;4(9):1151\u201365. https:\/\/doi.org\/10.2217\/fmb.09.87.","journal-title":"Future Microbiol"},{"issue":"12","key":"5110_CR134","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/pharmaceutics16121525","volume":"16","author":"IL Dejeu","year":"2024","unstructured":"Dejeu IL, Vica\u0219 LG, Marian E, Ganea M, Fren\u021b OD, Maghiar PB, et al. Innovative approaches to enhancing the biomedical properties of liposomes. Pharmaceutics. 2024;16(12):1525.","journal-title":"Pharmaceutics"},{"key":"5110_CR135","doi-asserted-by":"publisher","unstructured":"Saputra H, Safaat M, Santoso P, Wakabayashi R, Goto M, Taira T, et al. Design of Protease-Responsive Antifungal Liposomal Formulation Decorated with a Lipid-Modified Chitin-Binding Domain. Int J Mol Sci. 2024;25(7). https:\/\/doi.org\/10.3390\/ijms25073567.","DOI":"10.3390\/ijms25073567"},{"key":"5110_CR136","doi-asserted-by":"publisher","unstructured":"Agamennone M, Fantacuzzi M, Vivenzio G, Scala MC, Campiglia P, Superti F, et al. Antiviral Peptides as Anti-Influenza Agents. Int J Mol Sci. 2022;23(19). https:\/\/doi.org\/10.3390\/ijms231911433.","DOI":"10.3390\/ijms231911433"},{"key":"5110_CR137","doi-asserted-by":"publisher","first-page":"104930","DOI":"10.1016\/j.micpath.2021.104930","volume":"155","author":"SS Solanki","year":"2021","unstructured":"Solanki SS, Singh P, Kashyap P, Sansi MS, Ali SA. Promising role of defensins peptides as therapeutics to combat against viral infection. Microb Pathog. 2021;155:104930. https:\/\/doi.org\/10.1016\/j.micpath.2021.104930.","journal-title":"Microb Pathog"},{"key":"5110_CR138","doi-asserted-by":"publisher","unstructured":"Tonk M, R\u016f\u017eek D, Vilcinskas A. Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2. Viruses. 2021;13(5). https:\/\/doi.org\/10.3390\/v13050912.","DOI":"10.3390\/v13050912"},{"key":"5110_CR139","doi-asserted-by":"publisher","unstructured":"Otto DP, de Villiers MM. Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections. Molecules. 2020;25(15). https:\/\/doi.org\/10.3390\/molecules25153415.","DOI":"10.3390\/molecules25153415"},{"key":"5110_CR140","doi-asserted-by":"publisher","first-page":"127768","DOI":"10.1016\/j.jtemb.2025.127768","volume":"92","author":"JM Carvalho-Silva","year":"2025","unstructured":"Carvalho-Silva JM, dos Reis AC. Antiviral activity of silver and selenium nanoparticles against SARS-CoV-2: a comprehensive systematic review of in vitro, in vivo, and clinical evidence. J Trace Elem Med Biol. 2025;92:127768. https:\/\/doi.org\/10.1016\/j.jtemb.2025.127768.","journal-title":"J Trace Elem Med Biol"},{"issue":"4","key":"5110_CR141","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/microorganisms13040952","volume":"13","author":"E Casals","year":"2025","unstructured":"Casals E, Gusta MF, Bastus N, Rello J, Puntes V. Silver nanoparticles and antibiotics: a promising synergistic approach to multidrug-resistant infections. Microorganisms. 2025;13(4):952.","journal-title":"Microorganisms"},{"issue":"24","key":"5110_CR142","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1016\/j.jmb.2013.09.038","volume":"425","author":"SS Wilson","year":"2013","unstructured":"Wilson SS, Wiens ME, Smith JG. Antiviral mechanisms of human defensins. J Mol Biol. 2013;425(24):4965\u201380. https:\/\/doi.org\/10.1016\/j.jmb.2013.09.038.","journal-title":"J Mol Biol"},{"key":"5110_CR143","doi-asserted-by":"publisher","first-page":"119561","DOI":"10.1016\/j.lfs.2021.119561","volume":"278","author":"S Dawre","year":"2021","unstructured":"Dawre S, Maru S. Human respiratory viral infections: current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment. Life Sci. 2021;278:119561. https:\/\/doi.org\/10.1016\/j.lfs.2021.119561.","journal-title":"Life Sci"},{"issue":"1","key":"5110_CR144","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1128\/aac.45.1.331-334.2001","volume":"45","author":"KA Brogden","year":"2001","unstructured":"Brogden KA, Kalfa VC, Ackermann MR, Palmquist DE, McCray PB Jr., Tack BF. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother. 2001;45(1):331\u20134. https:\/\/doi.org\/10.1128\/aac.45.1.331-334.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5110_CR145","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0166-3542(03)00153-0","volume":"60","author":"PR Wyde","year":"2003","unstructured":"Wyde PR, Chetty SN, Jewell AM, Boivin G, Piedra PA. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 2003;60(1):51\u20139. https:\/\/doi.org\/10.1016\/s0166-3542(03)00153-0.","journal-title":"Antiviral Res"},{"key":"5110_CR146","doi-asserted-by":"publisher","unstructured":"Ghosh SK, Weinberg A. Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2. Front Mol Biosci. 2021;8. https:\/\/doi.org\/10.3389\/fmolb.2021.620806.","DOI":"10.3389\/fmolb.2021.620806"},{"issue":"8","key":"5110_CR147","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/v11080704","volume":"11","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Siman-Tov G, Hall G, Bhalla N, Narayanan A. Human antimicrobial peptides as therapeutics for viral infections. Viruses. 2019;11(8):704.","journal-title":"Viruses"},{"issue":"1","key":"5110_CR148","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00726-024-03427-0","volume":"56","author":"F Yang","year":"2024","unstructured":"Yang F, Ma Y. The application and prospects of antimicrobial peptides in antiviral therapy. Amino Acids. 2024;56(1):68. https:\/\/doi.org\/10.1007\/s00726-024-03427-0.","journal-title":"Amino Acids"},{"key":"5110_CR149","doi-asserted-by":"publisher","first-page":"100966","DOI":"10.1016\/j.mtbio.2024.100966","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang B, Wang L, Yang Q, Zhang Y, Qinglai T, Yang X, et al. Pulmonary inhalation for disease treatment: basic research and clinical translations. Mater Today Bio. 2024;25:100966. https:\/\/doi.org\/10.1016\/j.mtbio.2024.100966.","journal-title":"Mater Today Bio"},{"issue":"12","key":"5110_CR150","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/ph17121742","volume":"17","author":"S Du","year":"2024","unstructured":"Du S, Wen Z, Yu J, Meng Y, Liu Y, Xia X. Breath and beyond: advances in nanomedicine for oral and intranasal aerosol drug delivery. Pharmaceuticals. 2024;17(12):1742.","journal-title":"Pharmaceuticals"},{"key":"5110_CR151","doi-asserted-by":"publisher","first-page":"103704","DOI":"10.1016\/j.scs.2022.103704","volume":"79","author":"Y Sheikhnejad","year":"2022","unstructured":"Sheikhnejad Y, Aghamolaei R, Fallahpour M, Motamedi H, Moshfeghi M, Mirzaei PA, et al. Airborne and aerosol pathogen transmission modeling of respiratory events in buildings: An overview of computational fluid dynamics. Sustain Cities Soc. 2022;79:103704. https:\/\/doi.org\/10.1016\/j.scs.2022.103704.","journal-title":"Sustain Cities Soc"},{"issue":"2","key":"5110_CR152","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/jamp.2015.1270","volume":"29","author":"C Darquenne","year":"2016","unstructured":"Darquenne C, Fleming JS, Katz I, Martin AR, Schroeter J, Usmani OS, et al. Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung. J Aerosol Med Pulm Drug Deliv. 2016;29(2):107\u201326. https:\/\/doi.org\/10.1089\/jamp.2015.1270.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"5110_CR153","doi-asserted-by":"publisher","first-page":"124165","DOI":"10.1016\/j.ijpharm.2024.124165","volume":"657","author":"D Gou","year":"2024","unstructured":"Gou D, Zhu Q, Chan H-K, Kourmatzis A, Cheng S, Yang R. Effects of the deformation and size of the upper airway on the deposition of aerosols. Int J Pharm. 2024;657:124165. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124165.","journal-title":"Int J Pharm"},{"issue":"3","key":"5110_CR154","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/jamp.2013.1079","volume":"27","author":"C Darquenne","year":"2014","unstructured":"Darquenne C. Aerosol deposition in the human lung in reduced gravity. J Aerosol Med Pulm Drug Deliv. 2014;27(3):170\u20137. https:\/\/doi.org\/10.1089\/jamp.2013.1079.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"5110_CR155","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1208\/s12249-009-9313-3","volume":"10","author":"MS Hassan","year":"2009","unstructured":"Hassan MS, Lau RW. Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties. AAPS PharmSciTech. 2009;10(4):1252\u201362. https:\/\/doi.org\/10.1208\/s12249-009-9313-3.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"5110_CR156","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s43088-025-00646-6","volume":"14","author":"A Gholap","year":"2025","unstructured":"Gholap A, Pardeshi S, Giram P, Nangare S, Sodha S, Kapare H, et al. Breathing new life nanomedicines for pulmonary drug delivery: targeting approaches, experimental models, and regulatory aspects. Beni-Suef Univ J Basic Appl Sci. 2025;14(1):65. https:\/\/doi.org\/10.1186\/s43088-025-00646-6.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"1","key":"5110_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/a:1018952425107","volume":"10","author":"AJ Hickey","year":"1993","unstructured":"Hickey AJ, Martonen TB. Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives. Pharm Res. 1993;10(1):1\u20137. https:\/\/doi.org\/10.1023\/a:1018952425107.","journal-title":"Pharm Res"},{"key":"5110_CR158","doi-asserted-by":"publisher","first-page":"106436","DOI":"10.1016\/j.jaerosci.2024.106436","volume":"181","author":"M Jahed","year":"2024","unstructured":"Jahed M, Kozinski J, Pakzad L. Mucus, airway and plume temperature effects on pMDI-drug delivery in a mouth-throat airway: experimental and numerical studies. J Aerosol Sci. 2024;181:106436. https:\/\/doi.org\/10.1016\/j.jaerosci.2024.106436.","journal-title":"J Aerosol Sci"},{"issue":"3","key":"5110_CR159","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","volume":"145","author":"G Sahay","year":"2010","unstructured":"Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release. 2010;145(3):182\u201395. https:\/\/doi.org\/10.1016\/j.jconrel.2010.01.036.","journal-title":"J Control Release"},{"key":"5110_CR160","doi-asserted-by":"publisher","unstructured":"Cai D, Gao W, Li Z, Zhang Y, Xiao L, Xiao Y. Current Development of Nano-Drug Delivery to Target Macrophages. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10051203.","DOI":"10.3390\/biomedicines10051203"},{"issue":"1","key":"5110_CR161","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/10611860290007504","volume":"10","author":"NR Mathia","year":"2002","unstructured":"Mathia NR, Timoszyk J, Stetsko PI, Megill JR, Smith RL, Wall DA. Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J Drug Target. 2002;10(1):31\u201340. https:\/\/doi.org\/10.1080\/10611860290007504.","journal-title":"J Drug Target"},{"key":"5110_CR162","doi-asserted-by":"publisher","first-page":"113862","DOI":"10.1016\/j.addr.2021.113862","volume":"177","author":"MA Selo","year":"2021","unstructured":"Selo MA, Sake JA, Kim K-J, Ehrhardt C. In vitro and ex vivo models in inhalation biopharmaceutical research \u2014 advances, challenges and future perspectives. Adv Drug Deliv Rev. 2021;177:113862. https:\/\/doi.org\/10.1016\/j.addr.2021.113862.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"5110_CR163","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1016\/j.xphs.2022.08.005","volume":"111","author":"D Ciloglu","year":"2022","unstructured":"Ciloglu D, Karaman A. A numerical simulation of the airflow and aerosol particle deposition in a realistic airway model of a healthy adult. J Pharm Sci. 2022;111(11):3130\u201340. https:\/\/doi.org\/10.1016\/j.xphs.2022.08.005.","journal-title":"J Pharm Sci"},{"key":"5110_CR164","doi-asserted-by":"publisher","first-page":"114641","DOI":"10.1016\/j.addr.2022.114641","volume":"192","author":"F Man","year":"2023","unstructured":"Man F, Tang J, Swedrowska M, Forbes B, R TMdR. Imaging drug delivery to the lungs: methods and applications in oncology. Adv Drug Deliv Rev. 2023;192:114641. https:\/\/doi.org\/10.1016\/j.addr.2022.114641.","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl 1","key":"5110_CR165","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/13547500902965120","volume":"14","author":"W Hofmann","year":"2009","unstructured":"Hofmann W. Modelling particle deposition in human lungs: modelling concepts and comparison with experimental data. Biomarkers. 2009;14(Suppl 1):59\u201362. https:\/\/doi.org\/10.1080\/13547500902965120.","journal-title":"Biomarkers"},{"issue":"36","key":"5110_CR166","doi-asserted-by":"publisher","first-page":"24650","DOI":"10.1021\/acsnano.3c10797","volume":"18","author":"Z Bai","year":"2024","unstructured":"Bai Z, Wan D, Lan T, Hong W, Dong H, Wei Y, et al. Nanoplatform based intranasal vaccines: current progress and clinical challenges. ACS Nano. 2024;18(36):24650\u201381. https:\/\/doi.org\/10.1021\/acsnano.3c10797.","journal-title":"ACS Nano"},{"issue":"1","key":"5110_CR167","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i1.20","volume":"21","author":"SP Newman","year":"2004","unstructured":"Newman SP, Pitcairn GR, Dalby RN. Drug delivery to the nasal cavity: in vitro and in vivo assessment. Crit Rev Ther Drug Carrier Syst. 2004;21(1):21\u201366.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"3","key":"5110_CR168","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.4049\/jimmunol.175.3.1776","volume":"175","author":"F Niyonsaba","year":"2005","unstructured":"Niyonsaba F, Ushio H, Nagaoka I, Okumura K, Ogawa H. The Human \u03b2-Defensins (-1, -2, -3, -4) and Cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary Human Keratinocytes1. J Immunol. 2005;175(3):1776\u201384. https:\/\/doi.org\/10.4049\/jimmunol.175.3.1776.","journal-title":"J Immunol"},{"key":"5110_CR169","doi-asserted-by":"publisher","first-page":"113189","DOI":"10.1016\/j.biopha.2022.113189","volume":"151","author":"PN Dlozi","year":"2022","unstructured":"Dlozi PN, Gladchuk A, Crutchley RD, Keuler N, Coetzee R, Dube A. Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes. Biomed Pharmacother. 2022;151:113189. https:\/\/doi.org\/10.1016\/j.biopha.2022.113189.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"5110_CR170","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.tips.2021.12.006","volume":"43","author":"CM de Souza","year":"2022","unstructured":"de Souza CM, da Silva \u00c1P, J\u00fanior NGO, Mart\u00ednez OF, Franco OL. Peptides as a therapeutic strategy against Klebsiella pneumoniae. Trends Pharmacol Sci. 2022;43(4):335\u201348. https:\/\/doi.org\/10.1016\/j.tips.2021.12.006.","journal-title":"Trends Pharmacol Sci"},{"key":"5110_CR171","doi-asserted-by":"publisher","unstructured":"Dehbashi S, Tahmasebi H, Alikhani MY, Shahbazi MA, Arabestani MR. Staphopain mediated virulence and antibiotic resistance alteration in co-infection of Staphylococcus aureus and Pseudomonas aeruginosa: an animal model. BMC Biotechnology. 2024;24(1). https:\/\/doi.org\/10.1186\/s12896-024-00840-x.","DOI":"10.1186\/s12896-024-00840-x"},{"issue":"4","key":"5110_CR172","first-page":"70","volume":"7","author":"H Tahmasebi","year":"2018","unstructured":"Tahmasebi H, Dehbashi S, Arabestani MR. High resolution melting curve analysis method for detecting of carbapenemases producing Pseudomonas aeruginosa. J Krishna Inst Med Sci Univ. 2018;7(4):70\u20137.","journal-title":"J Krishna Inst Med Sci Univ"},{"key":"5110_CR173","doi-asserted-by":"publisher","unstructured":"Tahmasebi H, Babaeizad A, Mohammadlou M, Alibabaei F, Banihashemian SZ, Eslami M. Reemergence of Mycoplasma pneumoniae disease: Pathogenesis and new approaches. Microbial Pathogenesis. 2024;196. https:\/\/doi.org\/10.1016\/j.micpath.2024.106944.","DOI":"10.1016\/j.micpath.2024.106944"},{"issue":"5","key":"5110_CR174","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.arbres.2021.09.007","volume":"58","author":"L Ageitos","year":"2022","unstructured":"Ageitos L, de la Fuente-Nunez C. Antimicrobial peptides: potential therapeutics against drug-resistant pulmonary infections. Arch Bronconeumol. 2022;58(5):383\u20135. https:\/\/doi.org\/10.1016\/j.arbres.2021.09.007.","journal-title":"Arch Bronconeumol"},{"key":"5110_CR175","doi-asserted-by":"publisher","first-page":"100367","DOI":"10.1016\/j.crmicr.2025.100367","volume":"8","author":"A Jouault","year":"2025","unstructured":"Jouault A, Jeguirim I, Kaddour IBH, Touqui L. Assessment of the efficacy of an antimicrobial peptide in the context of cystic fibrosis airways. Current Research in Microbial Sciences. 2025;8:100367. https:\/\/doi.org\/10.1016\/j.crmicr.2025.100367.","journal-title":"Current Research in Microbial Sciences"},{"issue":"7","key":"5110_CR176","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1513\/AnnalsATS.202008-925OC","volume":"18","author":"KL Winthrop","year":"2021","unstructured":"Winthrop KL, Flume PA, Thomson R, Mange KC, Yuen DW, Ciesielska M, et al. Amikacin liposome inhalation suspension for Mycobacterium avium Complex Lung Disease: A 12-month open-label extension clinical trial. Ann Am Thorac Soc. 2021;18(7):1147\u201357. https:\/\/doi.org\/10.1513\/AnnalsATS.202008-925OC.","journal-title":"Ann Am Thorac Soc"},{"key":"5110_CR177","doi-asserted-by":"publisher","first-page":"108406","DOI":"10.1016\/j.rmed.2025.108406","volume":"249","author":"KL Winthrop","year":"2025","unstructured":"Winthrop KL, Waweru C, Welch E, Wang P, Markson LE. Persistent use of amikacin liposome inhalation suspension associated with lower risk of hospitalizations and emergency room visits in refractory Mycobacterium avium Complex Lung Disease. Respir Med. 2025;249:108406. https:\/\/doi.org\/10.1016\/j.rmed.2025.108406.","journal-title":"Respir Med"},{"key":"5110_CR178","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1016\/j.bioflm.2023.100111","volume":"5","author":"E Chee","year":"2023","unstructured":"Chee E, Garc\u00eda AJ. Biomaterial therapeutic strategies for treatment of bacterial lung infections. Biofilm. 2023;5:100111. https:\/\/doi.org\/10.1016\/j.bioflm.2023.100111.","journal-title":"Biofilm"},{"key":"5110_CR179","doi-asserted-by":"publisher","unstructured":"Xue Y, Hou X, Wang S, Zhang Y, Zhong Y, Kang DD, et al. Antimicrobial peptide delivery to lung as peptibody mRNA in anti-inflammatory lipids treats multidrug-resistant bacterial pneumonia. Nat Biotechnol. 2025. https:\/\/doi.org\/10.1038\/s41587-025-02928-x.","DOI":"10.1038\/s41587-025-02928-x"},{"issue":"1","key":"5110_CR180","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1038\/s41467-025-65449-w","volume":"16","author":"C Zhong","year":"2025","unstructured":"Zhong C, He Y, Zou J, Gao L, Wang J, Zhu J, et al. An antimicrobial peptide as a potential therapy for bacterial pneumonia that alleviates antimicrobial resistance. Nat Commun. 2025;16(1):10488. https:\/\/doi.org\/10.1038\/s41467-025-65449-w.","journal-title":"Nat Commun"},{"key":"5110_CR181","doi-asserted-by":"publisher","unstructured":"Roque-Borda CA, Vishwakarma SK, Ramirez Delgado OJ, de Souza Rodrigues HL, Primo LMD, Campos IC, et al. Peptide-Based Strategies Against Mycobacterium tuberculosis Covering Immunomodulation, Vaccines, Synergistic Therapy, and Nanodelivery. Pharmaceuticals (Basel). 2025;18(10). https:\/\/doi.org\/10.3390\/ph18101440.","DOI":"10.3390\/ph18101440"},{"issue":"2","key":"5110_CR182","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/acsinfecdis.4c00806","volume":"11","author":"S Saini","year":"2025","unstructured":"Saini S, Pal S, Sharma R. Decoding the role of antimicrobial peptides in the fight against Mycobacterium tuberculosis. ACS Infect Dis. 2025;11(2):350\u201365. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00806.","journal-title":"ACS Infect Dis"},{"issue":"1","key":"5110_CR183","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","volume":"23","author":"S Zheng","year":"2025","unstructured":"Zheng S, Tu Y, Li B, Qu G, Li A, Peng X, et al. Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. J Transl Med. 2025;23(1):292. https:\/\/doi.org\/10.1186\/s12967-025-06321-9.","journal-title":"J Transl Med"},{"key":"5110_CR184","doi-asserted-by":"publisher","first-page":"1637254","DOI":"10.3389\/fmicb.2025.1637254","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu R, Sun M, Li X, Fang R, Xing J, et al. Progress of anti-tuberculosis drug targets and novel therapeutic strategies. Front Microbiol. 2025;16:1637254. https:\/\/doi.org\/10.3389\/fmicb.2025.1637254.","journal-title":"Front Microbiol"},{"key":"5110_CR185","doi-asserted-by":"publisher","first-page":"127152","DOI":"10.1016\/j.micres.2022.127152","volume":"263","author":"F Bugli","year":"2022","unstructured":"Bugli F, Martini C, Di Vito M, Cacaci M, Catalucci D, Gori A, et al. Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: a review. Microbiol Res. 2022;263:127152. https:\/\/doi.org\/10.1016\/j.micres.2022.127152.","journal-title":"Microbiol Res"},{"issue":"12","key":"5110_CR186","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1128\/aac.45.12.3437-3444.2001","volume":"45","author":"US Sajjan","year":"2001","unstructured":"Sajjan US, Tran LT, Sole N, Rovaldi C, Akiyama A, Friden PM, et al. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob Agents Chemother. 2001;45(12):3437\u201344. https:\/\/doi.org\/10.1128\/aac.45.12.3437-3444.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"5110_CR187","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1021\/acs.jmedchem.2c00270","volume":"65","author":"D Ben Hur","year":"2022","unstructured":"Ben Hur D, Kapach G, Wani NA, Kiper E, Ashkenazi M, Smollan G, et al. Antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa biofilm from cystic fibrosis patients. J Med Chem. 2022;65(13):9050\u201362. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00270.","journal-title":"J Med Chem"},{"issue":"4","key":"5110_CR188","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/jac\/dkaa529","volume":"76","author":"M D\u00edez-Aguilar","year":"2021","unstructured":"D\u00edez-Aguilar M, Hern\u00e1ndez-Garc\u00eda M, Morosini MI, Fluit A, Tunney MM, Huertas N, et al. Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates. J Antimicrob Chemother. 2021;76(4):984\u201392. https:\/\/doi.org\/10.1093\/jac\/dkaa529.","journal-title":"J Antimicrob Chemother"},{"key":"5110_CR189","doi-asserted-by":"publisher","unstructured":"Marcut L, Manescu Paltanea V, Antoniac A, Paltanea G, Robu A, Mohan AG, et al. Antimicrobial Solutions for Endotracheal Tubes in Prevention of Ventilator-Associated Pneumonia. Materials (Basel). 2023;16(14). https:\/\/doi.org\/10.3390\/ma16145034.","DOI":"10.3390\/ma16145034"},{"key":"5110_CR190","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.actbio.2023.01.001","volume":"158","author":"D Alves","year":"2023","unstructured":"Alves D, Grainha T, Pereira MO, Lopes SP. Antimicrobial materials for endotracheal tubes: a review on the last two decades of technological progress. Acta Biomater. 2023;158:32\u201355. https:\/\/doi.org\/10.1016\/j.actbio.2023.01.001.","journal-title":"Acta Biomater"},{"key":"5110_CR191","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.actbio.2019.04.042","volume":"91","author":"M Barnes","year":"2019","unstructured":"Barnes M, Feit C, Grant TA, Brisbois EJ. Antimicrobial polymer modifications to reduce microbial bioburden on endotracheal tubes and ventilator associated pneumonia. Acta Biomater. 2019;91:220\u201334. https:\/\/doi.org\/10.1016\/j.actbio.2019.04.042.","journal-title":"Acta Biomater"},{"key":"5110_CR192","doi-asserted-by":"publisher","first-page":"155222","DOI":"10.1016\/j.jcrc.2025.155222","volume":"91","author":"AK Richardson","year":"2026","unstructured":"Richardson AK, Fuller RG, April MD, Rizzo JA, Douin DJ, Moran MM, et al. Antimicrobial-coated endotracheal tubes: a narrative review. J Crit Care. 2026;91:155222. https:\/\/doi.org\/10.1016\/j.jcrc.2025.155222.","journal-title":"J Crit Care"},{"key":"5110_CR193","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.clineuro.2018.06.013","volume":"171","author":"K Rumalla","year":"2018","unstructured":"Rumalla K, Smith KA, Follett KA, Nazzaro JM, Arnold PM. Rates, causes, risk factors, and outcomes of readmission following deep brain stimulation for movement disorders: analysis of the U.S. Nationwide Readmissions Database. Clin Neurol Neurosurg. 2018;171:129\u201334. https:\/\/doi.org\/10.1016\/j.clineuro.2018.06.013.","journal-title":"Clin Neurol Neurosurg"},{"issue":"19","key":"5110_CR194","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.3390\/ijms251910269","volume":"25","author":"M Wouters","year":"2024","unstructured":"Wouters M, Van Moll L, De Vooght L, Choi\u0144ska E, Idaszek J, Szl\u0105zak K, et al. Polymyxin B Peptide Hydrogel Coating: A Novel Approach to Prevent Ventilator-Associated Pneumonia. Int J Mol Sci. 2024;25(19):10269.","journal-title":"Int J Mol Sci"},{"key":"5110_CR195","doi-asserted-by":"crossref","unstructured":"Coelho L, Moniz P, Guerreiro G, P\u00f3voa P. Airway and Respiratory Devices in the Prevention of Ventilator-Associated Pneumonia. Medicina. 2023;59(2):199.","DOI":"10.3390\/medicina59020199"},{"key":"5110_CR196","doi-asserted-by":"publisher","unstructured":"Ballard E, Yucel R, Melchers WJG, Brown AJP, Verweij PE, Warris A. Antifungal Activity of Antimicrobial Peptides and Proteins against Aspergillus fumigatus. J Fungi (Basel). 2020;6(2). https:\/\/doi.org\/10.3390\/jof6020065.","DOI":"10.3390\/jof6020065"},{"key":"5110_CR197","doi-asserted-by":"publisher","unstructured":"Willger SD, Grahl N, Cramer RA, Jr. Aspergillus fumigatus metabolism: clues to mechanisms of in vivo fungal growth and virulence. Med Mycol. 2009;47(1):S72\u20139. https:\/\/doi.org\/10.1080\/13693780802455313.","DOI":"10.1080\/13693780802455313"},{"issue":"4","key":"5110_CR198","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.rmr.2024.02.011","volume":"41","author":"C Rochard","year":"2024","unstructured":"Rochard C, Bigot J, Balloy V, Hennequin C, Guitard J. [Antimicrobial peptides: a new alternative for the treatment of aspergillosis]. Rev Mal Respir. 2024;41(4):283\u20138. https:\/\/doi.org\/10.1016\/j.rmr.2024.02.011.","journal-title":"Rev Mal Respir"},{"issue":"8","key":"5110_CR199","doi-asserted-by":"publisher","first-page":"e0234520","DOI":"10.1128\/aac.02345-20","volume":"65","author":"V Duncan","year":"2021","unstructured":"Duncan V, Smith D, Simpson L, Lovie E, Katvars L, Berge L, et al. Preliminary characterization of NP339, a novel polyarginine peptide with broad antifungal activity. Antimicrob Agents Chemother. 2021;65(8):e0234520. https:\/\/doi.org\/10.1128\/aac.02345-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"5110_CR200","doi-asserted-by":"publisher","unstructured":"Silva PM, Gon\u00e7alves S, Santos NC. Defensins: antifungal lessons from eukaryotes. Front Microbiol. 2014;5. https:\/\/doi.org\/10.3389\/fmicb.2014.00097.","DOI":"10.3389\/fmicb.2014.00097"},{"key":"5110_CR201","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2180-9-33","volume":"9","author":"L Alekseeva","year":"2009","unstructured":"Alekseeva L, Huet D, F\u00e9m\u00e9nia F, Mouyna I, Abdelouahab M, Cagna A, et al. Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol. 2009;9:33. https:\/\/doi.org\/10.1186\/1471-2180-9-33.","journal-title":"BMC Microbiol"},{"issue":"2","key":"5110_CR202","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/biomedicines11020513","volume":"11","author":"MI Khan","year":"2023","unstructured":"Khan MI, Choudhry H, Jahan S, Rather IA. Reversal of azole resistance in Candida albicans by human neutrophil peptide. Biomedicines. 2023;11(2):513.","journal-title":"Biomedicines"},{"key":"5110_CR203","doi-asserted-by":"publisher","unstructured":"Buda De Cesare G, Cristy SA, Garsin DA, Lorenz MC. Antimicrobial Peptides: a New Frontier in Antifungal Therapy. mBio. 2020;11(6). https:\/\/doi.org\/10.1128\/mBio.02123-20.","DOI":"10.1128\/mBio.02123-20"},{"key":"5110_CR204","doi-asserted-by":"publisher","unstructured":"Zhang Q, Choi K, Wang X, Xi L, Lu S. The Contribution of Human Antimicrobial Peptides to Fungi. Int J Mol Sci. 2025;26(6). https:\/\/doi.org\/10.3390\/ijms26062494.","DOI":"10.3390\/ijms26062494"},{"key":"5110_CR205","doi-asserted-by":"publisher","unstructured":"Prado MKB, Fontanari C, Souza COS, Gardinassi LG, Zoccal KF, de Paula-Silva FWG, et al. IL-22 Promotes IFN-\u03b3-Mediated Immunity against Histoplasma capsulatum Infection. Biomolecules. 2020;10(6). https:\/\/doi.org\/10.3390\/biom10060865.","DOI":"10.3390\/biom10060865"},{"issue":"3","key":"5110_CR206","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/ph18030364","volume":"18","author":"HF Hetta","year":"2025","unstructured":"Hetta HF, Melhem T, Aljohani HM, Salama A, Ahmed R, Elfadil H, et al. Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways. Pharmaceuticals. 2025;18(3):364.","journal-title":"Pharmaceuticals"},{"issue":"8","key":"5110_CR207","doi-asserted-by":"publisher","first-page":"183255","DOI":"10.1016\/j.bbamem.2020.183255","volume":"1862","author":"C Struyfs","year":"2020","unstructured":"Struyfs C, Cools TL, De Cremer K, Sampaio-Marques B, Ludovico P, Wasko BM, et al. The antifungal plant defensin HsAFP1 induces autophagy, vacuolar dysfunction and cell cycle impairment in yeast. Biochim Biophys Acta Biomembr. 2020;1862(8):183255. https:\/\/doi.org\/10.1016\/j.bbamem.2020.183255.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"1","key":"5110_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.43.1.1","volume":"43","author":"AJ De Lucca","year":"1999","unstructured":"De Lucca AJ, Walsh TJ. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob Agents Chemother. 1999;43(1):1\u201311. https:\/\/doi.org\/10.1128\/aac.43.1.1.","journal-title":"Antimicrob Agents Chemother"},{"key":"5110_CR209","doi-asserted-by":"publisher","unstructured":"Park J, Kim H, Kang HK, Choi MC, Park Y. Lycosin-II Exhibits Antifungal Activity and Inhibits Dual-Species Biofilm by Candida albicans and Staphylococcus aureus. J Fungi (Basel). 2022;8(9). https:\/\/doi.org\/10.3390\/jof8090901.","DOI":"10.3390\/jof8090901"},{"key":"5110_CR210","doi-asserted-by":"publisher","unstructured":"Mercer DK, O'Neil DA. Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.02177.","DOI":"10.3389\/fimmu.2020.02177"},{"issue":"16","key":"5110_CR211","doi-asserted-by":"publisher","first-page":"9264","DOI":"10.3390\/ijms23169264","volume":"23","author":"A Perez-Rodriguez","year":"2022","unstructured":"Perez-Rodriguez A, Eraso E, Quind\u00f3s G, Mateo E. Antimicrobial peptides with anti-Candida activity. Int J Mol Sci. 2022;23(16):9264.","journal-title":"Int J Mol Sci"},{"key":"5110_CR212","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jare.2024.01.023","volume":"67","author":"B Xu","year":"2025","unstructured":"Xu B, Wang L, Yang C, Yan R, Zhang P, Jin M, et al. Specifically targeted antimicrobial peptides synergize with bacterial-entrapping peptide against systemic MRSA infections. J Adv Res. 2025;67:301\u201315. https:\/\/doi.org\/10.1016\/j.jare.2024.01.023.","journal-title":"J Adv Res"},{"key":"5110_CR213","doi-asserted-by":"publisher","unstructured":"Cappiello F, Casciaro B, Loffredo MR, Puglisi E, Lin Q, Yang D, et al. Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases. Pharmaceutics. 2022;14(11). https:\/\/doi.org\/10.3390\/pharmaceutics14112297.","DOI":"10.3390\/pharmaceutics14112297"},{"issue":"2","key":"5110_CR214","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1039\/d4md00745j","volume":"16","author":"G Kumar","year":"2025","unstructured":"Kumar G. Natural peptides and their synthetic congeners acting against Acinetobacter baumannii through the membrane and cell wall: latest progress. RSC Med Chem. 2025;16(2):561\u2013604. https:\/\/doi.org\/10.1039\/d4md00745j.","journal-title":"RSC Med Chem"},{"key":"5110_CR215","doi-asserted-by":"publisher","unstructured":"Oliveira GS, Costa RP, Gomes P, Gomes MS, Silva T, Teixeira C. Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review. Pharmaceuticals (Basel). 2021;14(4). https:\/\/doi.org\/10.3390\/ph14040323.","DOI":"10.3390\/ph14040323"},{"key":"5110_CR216","doi-asserted-by":"publisher","unstructured":"Fantone KM, Goldberg JB, Stecenko AA, Rada B. Sputum from People with Cystic Fibrosis Reduces the Killing of Methicillin-Resistant Staphylococcus aureus by Neutrophils and Diminishes Phagosomal Production of Reactive Oxygen Species. Pathogens. 2023;12(9). https:\/\/doi.org\/10.3390\/pathogens12091148.","DOI":"10.3390\/pathogens12091148"},{"key":"5110_CR217","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fimmu.2019.00283","volume":"10","author":"XL Luo","year":"2019","unstructured":"Luo XL, Li JX, Huang HR, Duan JL, Dai RX, Tao RJ, et al. LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation. Front Immunol. 2019;10:283. https:\/\/doi.org\/10.3389\/fimmu.2019.00283.","journal-title":"Front Immunol"},{"issue":"2","key":"5110_CR218","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/alr.21851","volume":"7","author":"EE Cottrill","year":"2017","unstructured":"Cottrill EE, Chen B, Adappa ND, Palmer JN, Kennedy DW, Lee RJ, et al. Expression of dermcidin in human sinonasal secretions. Int Forum Allergy Rhinol. 2017;7(2):154\u20139. https:\/\/doi.org\/10.1002\/alr.21851.","journal-title":"Int Forum Allergy Rhinol"},{"key":"5110_CR219","doi-asserted-by":"publisher","unstructured":"del Olmo Ml, Andreu C. Current Status of the Application of Antimicrobial Peptides and Their Conjugated Derivatives. Molecules. 2025. https:\/\/doi.org\/10.3390\/molecules30153070.","DOI":"10.3390\/molecules30153070"},{"issue":"5","key":"5110_CR220","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/acsbiomaterials.0c01084","volume":"7","author":"L Yang","year":"2021","unstructured":"Yang L, Liu Y, Wang N, Wang H, Wang K, Luo XL, et al. Albumin-based LL37 peptide nanoparticles as a sustained release system against Pseudomonas aeruginosa lung infection. ACS Biomater Sci Eng. 2021;7(5):1817\u201326. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01084.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"5110_CR221","doi-asserted-by":"publisher","first-page":"107398","DOI":"10.1016\/j.ijantimicag.2024.107398","volume":"65","author":"AK Keshri","year":"2025","unstructured":"Keshri AK, Rawat SS, Chaudhary A, Sharma S, Kapoor A, Mehra P, et al. LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity. Int J Antimicrob Agents. 2025;65(1):107398. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107398.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"5110_CR222","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/acsomega.2c04078","volume":"8","author":"A Sharma","year":"2023","unstructured":"Sharma A, Shambhwani D, Pandey S, Singh J, Lalhlenmawia H, Kumarasamy M, et al. Advances in lung cancer treatment using nanomedicines. ACS Omega. 2023;8(1):10\u201341. https:\/\/doi.org\/10.1021\/acsomega.2c04078.","journal-title":"ACS Omega"},{"key":"5110_CR223","doi-asserted-by":"publisher","unstructured":"Cresti L, Cappello G, Vailati S, Melloni E, Brunetti J, Falciani C, et al. In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097967.","DOI":"10.3390\/ijms24097967"},{"issue":"12","key":"5110_CR224","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/j.1365-2222.1997.tb02987.x","volume":"27","author":"A Romano","year":"1997","unstructured":"Romano A, Torres MJ, Fernandez J, Vega JM, Mayorga C, Garcia J, et al. Allergic reactions to ampicillin. Studies on the specificity and selectivity in subjects with immediate reactions. Clin Exp Allergy. 1997;27(12):1425\u201331.","journal-title":"Clin Exp Allergy"},{"key":"5110_CR225","doi-asserted-by":"publisher","unstructured":"Alsaleh NB, Brown JM. Engineered Nanomaterials and Type I Allergic Hypersensitivity Reactions. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.00222.","DOI":"10.3389\/fimmu.2020.00222"},{"issue":"1","key":"5110_CR226","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40560-015-0072-9","volume":"3","author":"M Gurjar","year":"2015","unstructured":"Gurjar M. Colistin for lung infection: an update. J Intensive Care. 2015;3(1):3. https:\/\/doi.org\/10.1186\/s40560-015-0072-9.","journal-title":"J Intensive Care"},{"key":"5110_CR227","doi-asserted-by":"publisher","unstructured":"Scoffone VC, Barbieri G, Irudal S, Trespidi G, Buroni S. New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis. Antibiotics. 2024. https:\/\/doi.org\/10.3390\/antibiotics13010071.","DOI":"10.3390\/antibiotics13010071"},{"key":"5110_CR228","first-page":"001","volume":"7","author":"MAB Naafs","year":"2018","unstructured":"Naafs MAB. The antimicrobial peptides: ready for clinical trials? Biomed J Sci Tech Res. 2018;7:001\u20135.","journal-title":"Biomed J Sci Tech Res"},{"issue":"1","key":"5110_CR229","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1164\/rccm.200504-656OC","volume":"173","author":"M Kollef","year":"2006","unstructured":"Kollef M, Pittet D, S\u00e1nchez Garc\u00eda M, Chastre J, Fagon JY, Bonten M, et al. A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2006;173(1):91\u20137. https:\/\/doi.org\/10.1164\/rccm.200504-656OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5110_CR230","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1038\/ncomms13002","volume":"7","author":"N Jochumsen","year":"2016","unstructured":"Jochumsen N, Marvig RL, Damki\u00e6r S, Jensen RL, Paulander W, Molin S, et al. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions. Nat Commun. 2016;7(1):13002. https:\/\/doi.org\/10.1038\/ncomms13002.","journal-title":"Nat Commun"},{"key":"5110_CR231","doi-asserted-by":"publisher","unstructured":"Grall N, Assadi M, Esposito-Farese M, Lortat-Jacob B, Tanaka S, Atchade E, et al. No Emergence of Colistin Resistance in the Respiratory Tract of Lung Transplant Patients Treated With Inhaled Colistin. Transpl Int. 2025;37. https:\/\/doi.org\/10.3389\/ti.2024.13545.","DOI":"10.3389\/ti.2024.13545"},{"key":"5110_CR232","doi-asserted-by":"publisher","unstructured":"Aye SM, Galani I, Yu H, Wang J, Chen K, Wickremasinghe H, et al. Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2020;64(8). https:\/\/doi.org\/10.1128\/aac.00246-20.","DOI":"10.1128\/aac.00246-20"},{"key":"5110_CR233","doi-asserted-by":"publisher","unstructured":"Jones F, Hu Y, Coates A. The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings. Antibiotics. 2022. https:\/\/doi.org\/10.3390\/antibiotics11030323.","DOI":"10.3390\/antibiotics11030323"},{"issue":"4","key":"5110_CR234","doi-asserted-by":"publisher","first-page":"e02115","DOI":"10.1128\/aem.02115-24","volume":"91","author":"Q Zhang","year":"2025","unstructured":"Zhang Q. Antimicrobial peptides: from discovery to developmental applications. Appl Environ Microbiol. 2025;91(4):e02115-e2124. https:\/\/doi.org\/10.1128\/aem.02115-24.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"5110_CR235","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1038\/s41598-021-83755-3","volume":"11","author":"KU Rao","year":"2021","unstructured":"Rao KU, Henderson DI, Krishnan N, Puthia M, Glegola-Madejska I, Brive L, et al. A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy. Sci Rep. 2021;11(1):4201. https:\/\/doi.org\/10.1038\/s41598-021-83755-3.","journal-title":"Sci Rep"},{"issue":"8","key":"5110_CR236","doi-asserted-by":"publisher","first-page":"e0397923","DOI":"10.1128\/spectrum.03979-23","volume":"12","author":"H Zhou","year":"2024","unstructured":"Zhou H, Du X, Wang Y, Kong J, Zhang X, Wang W, et al. Antimicrobial peptide A20L: in vitro and in vivo antibacterial and antibiofilm activity against carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr. 2024;12(8):e0397923. https:\/\/doi.org\/10.1128\/spectrum.03979-23.","journal-title":"Microbiol Spectr"},{"issue":"4","key":"5110_CR237","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1152\/physrev.00039.2023","volume":"104","author":"YP Di","year":"2024","unstructured":"Di YP, Kuhn JM, Mangoni ML. Lung antimicrobial proteins and peptides: from host defense to therapeutic strategies. Physiol Rev. 2024;104(4):1643\u201377. https:\/\/doi.org\/10.1152\/physrev.00039.2023.","journal-title":"Physiol Rev"},{"issue":"37","key":"5110_CR238","doi-asserted-by":"publisher","first-page":"e09567","DOI":"10.1002\/advs.202509567","volume":"12","author":"CA Roque-Borda","year":"2025","unstructured":"Roque-Borda CA, Medina-Alarc\u00f3n KP, Gon\u00e7alves Pereira JPS, Sevilhano T, Aguilar-Mor\u00f3n B, D\u00edaz-C\u00e1rdenas F, et al. Repositioning antimicrobial peptides against WHO-priority fungi. Adv Sci Weinh. 2025;12(37):e09567. https:\/\/doi.org\/10.1002\/advs.202509567.","journal-title":"Adv Sci Weinh"},{"key":"5110_CR239","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.drup.2023.100954","volume":"68","author":"J Xuan","year":"2023","unstructured":"Xuan J, Feng W, Wang J, Wang R, Zhang B, Bo L, et al. Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updat. 2023;68:100954. https:\/\/doi.org\/10.1016\/j.drup.2023.100954.","journal-title":"Drug Resist Updat"},{"issue":"14","key":"5110_CR240","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1039\/d1tb02617h","volume":"10","author":"A Rai","year":"2022","unstructured":"Rai A, Ferr\u00e3o R, Palma P, Patricio T, Parreira P, Anes E, et al. Antimicrobial peptide-based materials: opportunities and challenges. J Mater Chem B. 2022;10(14):2384\u2013429. https:\/\/doi.org\/10.1039\/d1tb02617h.","journal-title":"J Mater Chem B"},{"key":"5110_CR241","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.pharmthera.2021.107990","volume":"232","author":"S Gera","year":"2022","unstructured":"Gera S, Kankuri E, Kogermann K. Antimicrobial peptides - unleashing their therapeutic potential using nanotechnology. Pharmacol Ther. 2022;232:107990. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107990.","journal-title":"Pharmacol Ther"},{"key":"5110_CR242","doi-asserted-by":"publisher","unstructured":"Das S, Poudel R, Dutta K, Konai MM. A review on small molecular mimics of antimicrobial peptides with an emphasis on the structure-activity relationship perspective. RSC Med Chem. 2025. https:\/\/doi.org\/10.1039\/d5md00407a.","DOI":"10.1039\/d5md00407a"},{"key":"5110_CR243","doi-asserted-by":"publisher","first-page":"127822","DOI":"10.1016\/j.micres.2024.127822","volume":"286","author":"C Bucataru","year":"2024","unstructured":"Bucataru C, Ciobanasu C. Antimicrobial peptides: opportunities and challenges in overcoming resistance. Microbiol Res. 2024;286:127822. https:\/\/doi.org\/10.1016\/j.micres.2024.127822.","journal-title":"Microbiol Res"},{"key":"5110_CR244","doi-asserted-by":"publisher","first-page":"199642","DOI":"10.1016\/j.virusres.2025.199642","volume":"361","author":"M Mashhadi Abolghasem Shirazi","year":"2025","unstructured":"Mashhadi Abolghasem Shirazi M, Haghighat S, Nikbakht Z, Salimkia E, Kiumarsy A. Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions. Virus Res. 2025;361:199642. https:\/\/doi.org\/10.1016\/j.virusres.2025.199642.","journal-title":"Virus Res"},{"issue":"4","key":"5110_CR245","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1021\/acsptsci.0c00081","volume":"3","author":"BK Maiti","year":"2020","unstructured":"Maiti BK. Potential role of peptide-based antiviral therapy against SARS-CoV-2 infection. ACS Pharmacol Transl Sci. 2020;3(4):783\u20135. https:\/\/doi.org\/10.1021\/acsptsci.0c00081.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"5110_CR246","doi-asserted-by":"publisher","unstructured":"Todorovski T, Kalafatovic D, Andreu D. Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives. Pharmaceutics. 2023;15(2). https:\/\/doi.org\/10.3390\/pharmaceutics15020357.","DOI":"10.3390\/pharmaceutics15020357"},{"issue":"6","key":"5110_CR247","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1172\/jci15218","volume":"109","author":"T Ganz","year":"2002","unstructured":"Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest. 2002;109(6):693\u20137. https:\/\/doi.org\/10.1172\/jci15218.","journal-title":"J Clin Invest"},{"issue":"1","key":"5110_CR248","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1189\/jlb.0403150","volume":"75","author":"T Ganz","year":"2004","unstructured":"Ganz T. Antimicrobial polypeptides. J Leukoc Biol. 2004;75(1):34\u20138. https:\/\/doi.org\/10.1189\/jlb.0403150.","journal-title":"J Leukoc Biol"},{"key":"5110_CR249","doi-asserted-by":"publisher","first-page":"118486","DOI":"10.1016\/j.bmc.2025.118486","volume":"133","author":"M Tabarzad","year":"2026","unstructured":"Tabarzad M, Torshabi M, Haeri A, Fathi F, Mortazavi SM. Peptide-based antibiotics: structure-driven strategies to tackle toxicity and resistance of antimicrobial peptides. Bioorg Med Chem. 2026;133:118486. https:\/\/doi.org\/10.1016\/j.bmc.2025.118486.","journal-title":"Bioorg Med Chem"},{"key":"5110_CR250","doi-asserted-by":"publisher","first-page":"107137","DOI":"10.1016\/j.phrs.2024.107137","volume":"203","author":"Y Li","year":"2024","unstructured":"Li Y, Wu M, Fu Y, Xue J, Yuan F, Qu T, et al. Therapeutic stapled peptides: efficacy and molecular targets. Pharmacol Res. 2024;203:107137. https:\/\/doi.org\/10.1016\/j.phrs.2024.107137.","journal-title":"Pharmacol Res"},{"issue":"1","key":"5110_CR251","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2008.12.027","volume":"278","author":"KR Wang","year":"2009","unstructured":"Wang KR, Yan JX, Zhang BZ, Song JJ, Jia PF, Wang R. Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells. Cancer Lett. 2009;278(1):65\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2008.12.027.","journal-title":"Cancer Lett"},{"issue":"3","key":"5110_CR252","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1021\/acs.chemrev.6b00750","volume":"118","author":"H Jiang","year":"2018","unstructured":"Jiang H, Zhang X, Chen X, Aramsangtienchai P, Tong Z, Lin H. Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies. Chem Rev. 2018;118(3):919\u201388. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00750.","journal-title":"Chem Rev"},{"issue":"44","key":"5110_CR253","doi-asserted-by":"publisher","first-page":"30434","DOI":"10.1021\/jacs.4c10966","volume":"146","author":"CH Ji","year":"2024","unstructured":"Ji CH, Park S, Lee K, Je HW, Kang HS. Lipidation engineering in Daptomycin biosynthesis. J Am Chem Soc. 2024;146(44):30434\u201342. https:\/\/doi.org\/10.1021\/jacs.4c10966.","journal-title":"J Am Chem Soc"},{"key":"5110_CR254","doi-asserted-by":"publisher","unstructured":"Bellavita R, Braccia S, Galdiero S, Falanga A. Glycosylation and Lipidation Strategies: Approaches for Improving Antimicrobial Peptide Efficacy. Pharmaceuticals. 2023. https:\/\/doi.org\/10.3390\/ph16030439.","DOI":"10.3390\/ph16030439"},{"issue":"2","key":"5110_CR255","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","volume":"105","author":"PL Turecek","year":"2016","unstructured":"Turecek PL, Bossard MJ, Schoetens F, Ivens IA. PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs. J Pharm Sci. 2016;105(2):460\u201375. https:\/\/doi.org\/10.1016\/j.xphs.2015.11.015.","journal-title":"J Pharm Sci"},{"issue":"6","key":"5110_CR256","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/aac.06335-11","volume":"56","author":"CJ Morris","year":"2012","unstructured":"Morris CJ, Beck K, Fox MA, Ulaeto D, Clark GC, Gumbleton M. Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery. Antimicrob Agents Chemother. 2012;56(6):3298\u2013308. https:\/\/doi.org\/10.1128\/aac.06335-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5110_CR257","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1021\/acs.jmedchem.4c02852","volume":"68","author":"Y Shi","year":"2025","unstructured":"Shi Y, Luo G, Zhen B, Liu Z, Chen S, Wang Z, et al. Systematic all-hydrocarbon stapling analysis for Cecropin A generates a potent and stable antimicrobial peptide. J Med Chem. 2025;68(6):6372\u201385. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02852.","journal-title":"J Med Chem"},{"issue":"1","key":"5110_CR258","doi-asserted-by":"publisher","first-page":"e3533","DOI":"10.1002\/psc.3533","volume":"30","author":"M Zheng","year":"2024","unstructured":"Zheng M, Chen H, Li X, Chen S, Shi Y, Hu H. Discovery of a novel antifungal agent: all-hydrocarbon stapling modification of peptide Aurein1.2. J Pept Sci. 2024;30(1):e3533. https:\/\/doi.org\/10.1002\/psc.3533.","journal-title":"J Pept Sci"},{"issue":"10","key":"5110_CR259","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1016\/j.bioactmat.2021.03.004","volume":"6","author":"D Keskin","year":"2021","unstructured":"Keskin D, Zu G, Forson AM, Tromp L, Sjollema J, van Rijn P. Nanogels: a novel approach in antimicrobial delivery systems and antimicrobial coatings. Bioact Mater. 2021;6(10):3634\u201357. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.03.004.","journal-title":"Bioact Mater"},{"issue":"1","key":"5110_CR260","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s42003-023-04601-y","volume":"6","author":"M Usui","year":"2023","unstructured":"Usui M, Yoshii Y, Thiriet-Rupert S, Ghigo J-M, Beloin C. Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance. Commun Biol. 2023;6(1):275. https:\/\/doi.org\/10.1038\/s42003-023-04601-y.","journal-title":"Commun Biol"},{"issue":"2","key":"5110_CR261","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/jnt6020009","volume":"6","author":"DM AlQurashi","year":"2025","unstructured":"AlQurashi DM, AlQurashi TF, Alam RI, Shaikh S, Tarkistani MAM. Advanced nanoparticles in combating antibiotic resistance: current innovations and future directions. J Nanotheranostics. 2025;6(2):9.","journal-title":"J Nanotheranostics"},{"key":"5110_CR262","doi-asserted-by":"publisher","first-page":"0104","DOI":"10.34133\/bmef.0104","volume":"6","author":"JV Campos","year":"2025","unstructured":"Campos JV, Pontes JTC, Canales CSC, Roque-Borda CA, Pavan FR. Advancing nanotechnology: targeting biofilm-forming bacteria with antimicrobial peptides. BME Front. 2025;6:0104. https:\/\/doi.org\/10.34133\/bmef.0104.","journal-title":"BME Front"},{"issue":"4","key":"5110_CR263","doi-asserted-by":"publisher","first-page":"291","DOI":"10.12336\/biomatertransl.2023.04.008","volume":"4","author":"Y Shi","year":"2023","unstructured":"Shi Y, Hu H. AI accelerated discovery of self-assembling peptides. Biomater Transl. 2023;4(4):291\u20133. https:\/\/doi.org\/10.12336\/biomatertransl.2023.04.008.","journal-title":"Biomater Transl"},{"issue":"20","key":"5110_CR264","doi-asserted-by":"publisher","first-page":"2500043","DOI":"10.1002\/adma.202500043","volume":"37","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Feng J, Wang F, Wang J, Wang N, Zhang M, et al. AI-guided design of antimicrobial peptide hydrogels for precise treatment of drug-resistant bacterial infections. Adv Mater. 2025;37(20):2500043. https:\/\/doi.org\/10.1002\/adma.202500043.","journal-title":"Adv Mater"},{"key":"5110_CR265","doi-asserted-by":"publisher","unstructured":"Zhang H, Lv J, Ma Z, Ma J, Chen J. Advances in Antimicrobial Peptides: Mechanisms, Design Innovations, and Biomedical Potential. Molecules. 2025. https:\/\/doi.org\/10.3390\/molecules30071529.","DOI":"10.3390\/molecules30071529"},{"key":"5110_CR266","doi-asserted-by":"publisher","unstructured":"Jacobowski AC, Boleti AP, Cruz MV, Santos KF, de Andrade LR, Frihling BE, et al. Combating Antimicrobial Resistance: Innovative Strategies Using Peptides, Nanotechnology, Phages, Quorum Sensing Interference, and CRISPR-Cas Systems. Pharmaceuticals. 2025. https:\/\/doi.org\/10.3390\/ph18081119.","DOI":"10.3390\/ph18081119"},{"key":"5110_CR267","doi-asserted-by":"publisher","unstructured":"Nouri F, Alibabaei F, Forouzanmehr B, Tahmasebi H, Oksenych V, Eslami M. Progress in CRISPR Technology for Antiviral Treatments: Genome Editing as a Potential Cure for Chronic Viral Infections. Microbiology Research. 2025;16(5). https:\/\/doi.org\/10.3390\/microbiolres16050104.","DOI":"10.3390\/microbiolres16050104"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05110-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:29:05Z","timestamp":1781155745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05110-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":267,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5110"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05110-8","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"552"}}